<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea - Marjoribanks, J - 2015 | Cochrane Library</title> <meta content="Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea - Marjoribanks, J - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001751.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea - Marjoribanks, J - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001751.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001751.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea" name="citation_title"/> <meta content="Jane Marjoribanks" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="j.marjoribanks@auckland.ac.nz" name="citation_author_email"/> <meta content="Reuben Olugbenga Ayeleke" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Cindy Farquhar" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Michelle Proctor" name="citation_author"/> <meta content="Department of Corrections" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD001751.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/07/30" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001751.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001751.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001751.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Inflammatory Agents, Non‐Steroidal [adverse effects, *therapeutic use]; Cyclooxygenase Inhibitors [adverse effects, therapeutic use]; Dysmenorrhea [*drug therapy]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001751.pub3&amp;doi=10.1002/14651858.CD001751.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="PMzGcYGP";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001751\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001751\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","pt","ms","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001751.pub3",title:"Nonsteroidal anti\\u2010inflammatory drugs for dysmenorrhoea",firstPublishedDate:"Jul 30, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001751.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001751.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001751.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001751.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001751.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001751.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001751.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001751.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001751.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001751.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17370 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001751.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0123"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-sec-0114"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/appendices#CD001751-sec-0128"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/table_n/CD001751StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/table_n/CD001751StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#CD001751-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Jane Marjoribanks</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#CD001751-cr-0003">Reuben Olugbenga Ayeleke</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#CD001751-cr-0004">Cindy Farquhar</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information#CD001751-cr-0005">Michelle Proctor</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information/en#CD001751-sec-0139">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 30 July 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001751.pub3">https://doi.org/10.1002/14651858.CD001751.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001751-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001751-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001751-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001751-abs-0001" lang="en"> <section id="CD001751-sec-0001"> <h3 class="title" id="CD001751-sec-0001">Background</h3> <p>Dysmenorrhoea is a common gynaecological problem consisting of painful cramps accompanying menstruation, which in the absence of any underlying abnormality is known as primary dysmenorrhoea. Research has shown that women with dysmenorrhoea have high levels of prostaglandins, hormones known to cause cramping abdominal pain. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are drugs that act by blocking prostaglandin production. They inhibit the action of cyclooxygenase (COX), an enzyme responsible for the formation of prostaglandins. The COX enzyme exists in two forms, COX‐1 and COX‐2. Traditional NSAIDs are considered 'non‐selective' because they inhibit both COX‐1 and COX‐2 enzymes. More selective NSAIDs that solely target COX‐2 enzymes (COX‐2‐specific inhibitors) were launched in 1999 with the aim of reducing side effects commonly reported in association with NSAIDs, such as indigestion, headaches and drowsiness. </p> </section> <section id="CD001751-sec-0002"> <h3 class="title" id="CD001751-sec-0002">Objectives</h3> <p>To determine the effectiveness and safety of NSAIDs in the treatment of primary dysmenorrhoea.</p> </section> <section id="CD001751-sec-0003"> <h3 class="title" id="CD001751-sec-0003">Search methods</h3> <p>We searched the following databases in January 2015: Cochrane Menstrual Disorders and Subfertility Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL, November 2014 issue), MEDLINE, EMBASE and Web of Science. We also searched clinical trials registers (ClinicalTrials.gov and ICTRP). We checked the abstracts of major scientific meetings and the reference lists of relevant articles. </p> </section> <section id="CD001751-sec-0004"> <h3 class="title" id="CD001751-sec-0004">Selection criteria</h3> <p>All randomised controlled trial (RCT) comparisons of NSAIDs versus placebo, other NSAIDs or paracetamol, when used to treat primary dysmenorrhoea. </p> </section> <section id="CD001751-sec-0005"> <h3 class="title" id="CD001751-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected the studies, assessed their risk of bias and extracted data, calculating odds ratios (ORs) for dichotomous outcomes and mean differences for continuous outcomes, with 95% confidence intervals (CIs). We used inverse variance methods to combine data. We assessed the overall quality of the evidence using GRADE methods. </p> </section> <section id="CD001751-sec-0006"> <h3 class="title" id="CD001751-sec-0006">Main results</h3> <p>We included 80 randomised controlled trials (5820 women). They compared 20 different NSAIDs (18 non‐selective and two COX‐2‐specific) versus placebo, paracetamol or each other. </p> <p><b>NSAIDs versus placebo</b> </p> <p>Among women with primary dysmenorrhoea, NSAIDs were more effective for pain relief than placebo (OR 4.37, 95% CI 3.76 to 5.09; 35 RCTs, I<sup>2</sup> = 53%, low quality evidence). This suggests that if 18% of women taking placebo achieve moderate or excellent pain relief, between 45% and 53% taking NSAIDs will do so. </p> <p>However, NSAIDs were associated with more adverse effects (overall adverse effects: OR 1.29, 95% CI 1.11 to 1.51, 25 RCTs, I<sup>2</sup> = 0%, low quality evidence; gastrointestinal adverse effects: OR 1.58, 95% CI 1.12 to 2.23, 14 RCTs, I<sup>2</sup> = 30%; neurological adverse effects: OR 2.74, 95% CI 1.66 to 4.53, seven RCTs, I<sup>2</sup> = 0%, low quality evidence). The evidence suggests that if 10% of women taking placebo experience side effects, between 11% and 14% of women taking NSAIDs will do so. </p> <p><b>NSAIDs versus other NSAIDs</b> </p> <p>When NSAIDs were compared with each other there was little evidence of the superiority of any individual NSAID for either pain relief or safety. However, the available evidence had little power to detect such differences, as most individual comparisons were based on very few small trials. </p> <p><b>Non‐selective NSAIDs versus COX‐2‐specific selectors</b> </p> <p>Only two of the included studies utilised COX‐2‐specific inhibitors (etoricoxib and celecoxib). There was no evidence that COX‐2‐specific inhibitors were more effective or tolerable for the treatment of dysmenorrhoea than traditional NSAIDs; however data were very scanty. </p> <p><b>NSAIDs versus paracetamol</b> </p> <p>NSAIDs appeared to be more effective for pain relief than paracetamol (OR 1.89, 95% CI 1.05 to 3.43, three RCTs, I<sup>2</sup> = 0%, low quality evidence). There was no evidence of a difference with regard to adverse effects, though data were very scanty. </p> <p>Most of the studies were commercially funded (59%); a further 31% failed to state their source of funding. </p> </section> <section id="CD001751-sec-0007"> <h3 class="title" id="CD001751-sec-0007">Authors' conclusions</h3> <p>NSAIDs appear to be a very effective treatment for dysmenorrhoea, though women using them need to be aware of the substantial risk of adverse effects. There is insufficient evidence to determine which (if any) individual NSAID is the safest and most effective for the treatment of dysmenorrhoea. We rated the quality of the evidence as low for most comparisons, mainly due to poor reporting of study methods. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001751-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001751-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001751-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD001751-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001751-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001751-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001751-abs-0006">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001751-abs-0004" lang="en"> <h3>Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea</h3> <p><b>Review question</b> </p> <p>Are nonsteroidal anti‐inflammatory drugs (NSAIDs) safe and effective for relief of period pain (dysmenorrhoea) and how do they compare with each other and with paracetamol? </p> <p><b>Background</b> </p> <p>Nearly three‐quarters of women suffer from period pain or menstrual cramps (dysmenorrhoea). Research has shown that women with severe period pain have high levels of prostaglandins, hormones known to cause cramping abdominal pain. NSAIDs are drugs which act by blocking prostaglandin production. NSAIDs include the common painkillers aspirin, naproxen, ibuprofen and mefenamic acid. Researchers in The Cochrane Collaboration reviewed the evidence about the safety and effectiveness of NSAIDs for period pain. The evidence is current to January 2015. </p> <p><b>Study characteristics</b> </p> <p>We found 80 randomised controlled trials (RCTs), which included a total of 5820 women and compared 20 different types of NSAIDs with placebo (an inactive pill), paracetamol or each other. Most of the studies were commercially funded (59%), and a further 31% did not state their source of funding. </p> <p><b>Key results</b> </p> <p>The review found that NSAIDs appear to be very effective in relieving period pain. The evidence suggests that if 18% of women taking placebo achieve moderate or excellent pain relief, between 45% and 53% taking NSAIDs will do so. NSAIDs appear to work better than paracetamol, but it is unclear whether any one NSAID is safer or more effective than others. </p> <p>NSAIDs commonly cause adverse effects (side effects), including indigestion, headaches and drowsiness. The evidence suggests that if 10% of women taking placebo experience side effects, between 11% and 14% of women taking NSAIDs will do so. </p> <p>Based on two studies that made head‐to‐head comparisons, there was no evidence that newer types of NSAID (known as COX‐2‐specific inhibitors) are more effective for the treatment of dysmenorrhoea than traditional NSAIDs (known as non‐selective inhibitors), nor that there is a difference between them with regard to adverse effects. </p> <p><b>Quality of the evidence</b> </p> <p>We rated the quality of the evidence as low for most comparisons, mainly due to poor reporting of study methods. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001751-sec-0123" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-sec-0123">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-sec-0175">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001751-sec-0123"></div> <h3 class="title" id="CD001751-sec-0124">Implications for practice</h3> <section id="CD001751-sec-0124"> <p>Nonsteroidal anti‐inflammatory drugs (NSAIDs) appear to be a very effective treatment for dysmenorrhoea, though women using them need to be aware of the substantial risk that they may cause adverse effects such as indigestion or drowsiness. There is insufficient evidence to indicate whether any individual NSAID is more effective than others, but it appears that NSAIDs are more effective than paracetamol. Based on only two studies that made head‐to‐head comparisons, there was no evidence that COX‐2‐specific inhibitors are more effective or more tolerable than non‐selective NSAIDs, for the treatment of dysmenorrhoea. </p> </section> <h3 class="title" id="CD001751-sec-0125">Implications for research</h3> <section id="CD001751-sec-0125"> <p>Large numbers of women are needed for comparison in order to achieve sufficient statistical power to reveal any meaningful differences in efficacy and safety between NSAIDs for dysmenorrhoea. This can most easily be achieved by meta‐analysis. In order to facilitate this process, trial publications need to provide a detailed account of statistical methods used and present full results with summary effect measures and measures of variance. Attention to adequate reporting of trial methodology in line with the CONSORT statement, <a href="./references#CD001751-bbs2-0214" title="Consort statement. http://www.consort‐statement.org/consort‐statement/2001. ">CONSORT 2001</a>, remains a fundamental issue. </p> <p>If pain is measured as a continuous outcome, use of a validated scale such as a visual analogue scale (VAS) is recommended. </p> <p>Outcomes of combination therapies in comparison with NSAIDs alone would be a useful topic for a further systematic review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001751-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001751-sec-0022"></div> <div class="table" id="CD001751-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NSAIDs compared to placebo for dysmenorrhoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NSAIDs compared to placebo for dysmenorrhoea</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women with primary dysmenorrhoea </p> <p><b>Setting: Outpatient</b> <br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of studies</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk<sup>4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> NSAIDs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain relief dichotomous data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>490 per 1000<br/> (452 to 528) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 4.37<br/> (3.76 to 5.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All adverse effects</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>125 per 1000<br/> (110 to 144) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.29<br/> (1.11 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in a footnote. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NSAID:</b> nonsteroidal anti‐inflammatory drug; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Very poor reporting of study methods by over 75% of studies; high risk of attrition bias in several studies; over 60% of studies commercially sponsored.<br/> <sup>2</sup>Substantial heterogeneity (I² = 53%) but direction of effect consistent.<br/> <sup>3</sup>Some suggestion of publication bias, favouring small studies with positive findings for NSAIDs.<br/> <sup>4</sup>The control group risks are calculated from median values in 31 studies of pain relief and 19 of adverse effects in a previous version of this review. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001751-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAIDs compared to paracetamol for dysmenorrhoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NSAIDs compared to paracetamol for dysmenorrhoea</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women with primary dysmenorrhoea </p> <p><b>Setting: Outpatient</b> <br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> paracetamol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of studies</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk<sup>3</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Paracetamol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> NSAIDs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain relief dichotomous data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>630 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>763 per 1000<br/> (641 to 854) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.89<br/> (1.05 to 3.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All adverse effects ‐ ibuprofen versus paracetamol</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>130 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>113 per 1000<br/> (44 to 259) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.85<br/> (0.31 to 2.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in a footnote. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NSAID:</b> nonsteroidal anti‐inflammatory drug; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Poor reporting of study methods in two of the studies; high risk of attrition bias in one study; two of the studies commercially funded.<br/> <sup>2</sup>One small study, findings compatible with benefit/harm from either intervention, or with no difference between the interventions.<br/> <sup>3</sup>The control group risk is calculated from the median value in the included studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001751-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-sec-0147">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD001751-sec-0023"></div> <section id="CD001751-sec-0024"> <h3 class="title" id="CD001751-sec-0024">Description of the condition</h3> <p>Dysmenorrhoea refers to the occurrence of painful menstrual cramps of uterine origin, usually developing within hours of the start of menstruation and peaking as the flow becomes heaviest during the first day or two of the cycle. Pain is usually centred in the suprapubic area but may radiate to the back of the legs or lower back, and may be accompanied by other symptoms such as nausea, diarrhoea, headache and lightheadedness (<a href="./references#CD001751-bbs2-0213" title="CocoAS . Primary dysmenorrhea. American Family Physician1999;60:489‐96. ">Coco 1999</a>). Dysmenorrhoea is a common gynaecological complaint, though prevalence estimates vary widely. It was reported by 72% of Australian women of reproductive age in a recent nationally representative sample (<a href="./references#CD001751-bbs2-0229" title="PittsMK , FerrisJA , SmithAMA , ShelleyJM , RichtersJ . Prevalence and correlates of three types of pelvic pain in a nationally representative sample of Australian women. Medical Journal of Australia2008;189(3):138‐43. ">Pitts 2008</a>), and caused severe pain in 15% of cases. Other representative samples report rates ranging from 17% to 81% (<a href="./references#CD001751-bbs2-0226" title="LattheP , LattheM , SayL , GülmezogluM , KhanKS . WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health2006;6(177):1‐7. ">Latthe 2006</a>). In addition to the distress associated with dysmenorrhoea, surveys have shown significant socio‐economic repercussions: over 35% of female high school students report missing school due to menstrual pain (<a href="./references#CD001751-bbs2-0209" title="BanikarimC , ChackoMR , KelderSH . Prevalence and impact of dysmenorrhea on Hispanic female adolescents. Archives of Pediatrics and Adolescent Medicine2000;154(12):1226‐9. ">Banikarim 2000</a>; <a href="./references#CD001751-bbs2-0224" title="HillenTI , GrbavacSL , JohnstonPJ , StratonJA , KeoghJM . Primary dysmenorrhea in young Western Australian women: prevalence, impact and knowledge of treatment. Journal of Adolescent Health1999;25(1):40‐5. ">Hillen 1999</a>), and 15% of working Hungarian women of reproductive age reported that painful menstruation limited daily activity (<a href="./references#CD001751-bbs2-0225" title="LászlóKD , GyrffyZ , ÁdámS , CsobothC , KoppMS . Work‐related stress factors and menstrual pain: a nation‐wide representative survey. Journal of Psychosomatic Obstetrics and Gynecology2008;29(2):133‐8. ">Laszlo 2008</a>). </p> <p>Dysmenorrhoea is commonly defined within two subcategories. When menstrual pelvic pain is associated with an identifiable pathological condition, such as endometriosis or ovarian cysts, it is termed <i>secondary</i> dysmenorrhoea, while menstrual pain without organic pathology is termed <i>primary</i> dysmenorrhoea (<a href="./references#CD001751-bbs2-0227" title="LichtenEM , BombardJ . Surgical treatment of primary dysmenorrhea with laparoscopic uterine nerve ablation. Journal of Reproductive Medicine1987;32:37‐41. ">Lichten 1987</a>). The initial onset of primary dysmenorrhoea is usually with the first occurrence of menstruation (menarche), when ovulatory cycles are established, or within the following six to 12 months. The duration of pain is commonly 48 to 72 hours and accompanies menstrual flow or precedes it by only a few hours. In contrast, secondary dysmenorrhoea is more likely to occur years after the onset of menarche and pain can occur both before and during menstruation (<a href="./references#CD001751-bbs2-0215" title="DawoodMY . Ibuprofen and dysmenorrhea. American Journal of Medicine1984;77(1A):87‐94. ">Dawood 1984</a>). </p> <p>The aetiology of primary dysmenorrhoea has been the source of considerable debate. Current understanding is that it is caused by an excessive or imbalanced amount of prostanoids (hormone‐like substances including prostaglandin) released from the endometrium during menstruation. These cause the uterus to contract frequently and dysrhythmically, with reduced local blood flow and hyper sensitisation of the peripheral nerves (<a href="./references#CD001751-bbs2-0216" title="DawoodMY . Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics and Gynecology2006;108:428‐41. ">Dawood 2006</a>; <a href="./references#CD001751-bbs2-0023" title="DawoodMY , Khan‐DawoodFS . Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2a in a randomized, double blind crossover treatment with placebo, acetaminophen and ibuprofen in primary dysmenorrhea. American Journal of Obstetrics and Gynecology2007;196(35):e1‐35e5. ">Dawood 2007</a>). Although most women with dysmenorrhoea have higher levels of prostaglandins F2 alpha and E2 than non‐dysmenorrhoeic women (<a href="./references#CD001751-bbs2-0228" title="PicklesVR . Prostaglandins and dysmenorrhea: historical survey. Acta Obstetricia et Gynecologica Scandinavica Supplementum1979;87:7‐12. ">Pickles 1979</a>), some women with severe dysmenorrhoea and normal laparoscopic findings do not have elevated menstrual prostaglandin to account for the symptoms (<a href="./references#CD001751-bbs2-0212" title="ChanWY , DawoodMY , FuchsF . Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. American Journal of Obstetrics and Gynecology1979;135:102‐8. ">Chan 1978</a>). The prevalence of such cases is unknown. It has been suggested that the antidiuretic hormone vasopressin may also be involved in the aetiology of primary dysmenorrhoea, but its role remains controversial (<a href="./references#CD001751-bbs2-0216" title="DawoodMY . Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics and Gynecology2006;108:428‐41. ">Dawood 2006</a>). </p> </section> <section id="CD001751-sec-0025"> <h3 class="title" id="CD001751-sec-0025">Description of the intervention</h3> <p>Nonsteroidal anti‐inflammatory drugs (NSAIDs) are non‐narcotic analgesics. The first drug of this type was aspirin (acetylsalicylic acid), which was introduced in 1899. The term NSAID was first used in the 1950s when phenylbutazone was developed (<a href="./references#CD001751-bbs2-0221" title="HartFD , HuskissonEC . Non‐steroidal anti‐inflammatory drugs. Current status and rational therapeutic use. Drugs1984;27(2):232‐55. ">Hart 1984</a>). Since then NSAIDs have proliferated and many different types are available. NSAIDs inhibit the action of cyclooxygenase (COX), an enzyme responsible for the formation of prostaglandin (and other prostanoids). The COX enzyme exists in two forms, COX‐1 and COX‐2. Traditional NSAIDs are considered 'non‐selective' because they inhibit both COX‐1 and COX‐2 enzymes. The anti‐inflammatory and pain‐relieving effects of NSAIDs are thought to be mainly due to inhibition of COX‐2 enzymes, whereas the side effects (commonly gastrointestinal) appear to be related to the inhibition of COX‐1 enzymes. With the aim of improving the tolerability of NSAIDs, highly selective COX‐2‐specific inhibitors (coxibs) were developed and first launched in 1999. Since then there have been concerns regarding the risk of cardiovascular and/or dermatological adverse events associated with the long‐term use of some coxibs, and some have been withdrawn by manufacturers. There is growing evidence that NSAIDs as a class are associated with some degree of cardiovascular risk when used long‐term, as in the management of chronic pain in the elderly (<a href="./references#CD001751-bbs2-0236" title="ShiS , KlotzU . Clinical use and pharmacological properties of selective COX‐2 inhibitors. European Journal of Clinical Pharmacology2008;64:233‐52. ">Shi 2008</a>). </p> <p>Several other interventions for dysmenorrhoea have been assessed in Cochrane systematic reviews, as follows: </p> <p> <ul id="CD001751-list-0001"> <li> <p>surgical interruption of pelvic nerve pathways (<a href="./references#CD001751-bbs2-0232" title="ProctorM , LattheP , FarquharC , KhanK , JohnsonN . Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD001896.pub2] ">Proctor 2005</a>); </p> </li> <li> <p>herbal and dietary therapies (<a href="./references#CD001751-bbs2-0230" title="ProctorM , MurphyPA . Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database of Systematic Reviews2001, Issue 2. [DOI: 10.1002/14651858.CD002124] ">Proctor 2001</a>); </p> </li> <li> <p>spinal manipulation (<a href="./references#CD001751-bbs2-0233" title="ProctorM , HingW , JohnsonTC , MurphyPA , BrownJ . Spinal manipulation for dysmenorrhoea. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD002119.pub3] ">Proctor 2006</a>); </p> </li> <li> <p>beta2‐adrenoceptor agonists (<a href="./references#CD001751-bbs2-0220" title="FedorowiczZ , NasserM , JagannathVA , BeamanJH , EjazK , vanZuurenEJ . Beta2‐adrenoceptor agonists for dysmenorrhoea. Cochrane Database of Systematic Reviews2012, Issue 5. [DOI: 10.1002/14651858.CD008585.pub2] ">Fedorowicz 2012</a>); </p> </li> <li> <p>Chinese herbal medicine (<a href="./references#CD001751-bbs2-0241" title="ZhuX , ProctorM , BensoussanA , WuE , SmithCA . Chinese herbal medicine for primary dysmenorrhoea. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD005288] ">Zhu 2008</a>); </p> </li> <li> <p>oral contraceptive pill (<a href="./references#CD001751-bbs2-0238" title="WongCL , FarquharC , RobertsH , ProctorM . Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002120.pub3] ">Wong 2009</a>); </p> </li> <li> <p>transcutaneous electrical nerve stimulation (<a href="./references#CD001751-bbs2-0231" title="ProctorM , FarquharC , StonesW , HeL , ZhuX , BrownJ . Transcutaneous electrical nerve stimulation for primary dysmenorrhoea. Cochrane Database of Systematic Reviews2002, Issue 1. [DOI: 10.1002/14651858.CD002123] ">Proctor 2002</a>); </p> </li> <li> <p>exercise (<a href="./references#CD001751-bbs2-0211" title="BrownJ , BrownS . Exercise for dysmenorrhoea. Cochrane Database of Systematic Reviews2010, Issue 2. [DOI: 10.1002/14651858.CD004142.pub2] ">Brown 2010</a>); </p> </li> <li> <p>behavioural interventions (<a href="./references#CD001751-bbs2-0234" title="ProctorM , MurphyPA , PattisonHM , SucklingJA , FarquharC . Behavioural interventions for dysmenorrhoea. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD002248.pub3] ">Proctor 2007</a>); </p> </li> <li> <p>acupuncture (<a href="./references#CD001751-bbs2-0237" title="SmithCA , ZhuX , HeL , SongJ . Acupuncture for dysmenorrhoea. Cochrane Database of Systematic Reviews2011, Issue 1. [DOI: 10.1002/14651858.CD007854.pub2] ">Smith 2011</a>). </p> </li> </ul> </p> </section> <section id="CD001751-sec-0026"> <h3 class="title" id="CD001751-sec-0026">How the intervention might work</h3> <p>It is thought that NSAIDs relieve primary dysmenorrhoea mainly by suppressing the production of endometrial prostaglandins, thus alleviating cramps and restoring normal uterine activity. In addition there may be direct analgesic action on the central nervous system (<a href="./references#CD001751-bbs2-0216" title="DawoodMY . Primary dysmenorrhea: advances in pathogenesis and management. Obstetrics and Gynecology2006;108:428‐41. ">Dawood 2006</a>). </p> </section> <section id="CD001751-sec-0027"> <h3 class="title" id="CD001751-sec-0027">Why it is important to do this review</h3> <p>There is a large body of randomised controlled trials evaluating the short‐term use of NSAIDs for treatment of dysmenorrhoea. A previous systematic review of NSAIDs for dysmenorrhoea considered the four most commonly used types: aspirin, ibuprofen, mefenamic acid and naproxen (<a href="./references#CD001751-bbs2-0240" title="ZhangWY , Li Wan PoA . Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. British Journal of Obstetrics and Gynaecology1998;105:780‐9. ">Zhang 1998</a>). The purpose of the current review is to compare all nonsteroidal anti‐inflammatory drugs used in the treatment of primary dysmenorrhoea with placebo, with paracetamol and with each other to evaluate their effectiveness and safety. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001751-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-sec-0152">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001751-sec-0028"></div> <p>To determine the effectiveness and safety of NSAIDs in the treatment of primary dysmenorrhoea.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001751-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-sec-0029">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-sec-0153">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001751-sec-0029"></div> <section id="CD001751-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001751-sec-0031"> <h4 class="title">Types of studies</h4> <section id="CD001751-sec-0032"> <h5 class="title">Included</h5> <p>Published and unpublished randomised, controlled, double‐blinded trials using either a parallel‐group or cross‐over design. </p> </section> <section id="CD001751-sec-0033"> <h5 class="title">Excluded</h5> <p> <ul id="CD001751-list-0002"> <li> <p>Trials that failed to include in analysis at least 80% of the women initially randomised, with respect to at least one of the primary outcomes of this review. </p> </li> <li> <p>Unblinded or single‐blinded trials.</p> </li> </ul> </p> </section> </section> <section id="CD001751-sec-0034"> <h4 class="title">Types of participants</h4> <section id="CD001751-sec-0035"> <h5 class="title">Included</h5> <p> <ul id="CD001751-list-0003"> <li> <p>Women of reproductive age with primary dysmenorrhoea.</p> </li> </ul> </p> <p>We included trials where the diagnosis of dysmenorrhoea was not formally assessed with a physical or gynaecological examination provided no clinical indications of pelvic pathology were reported. </p> </section> <section id="CD001751-sec-0036"> <h5 class="title">Excluded</h5> <p>Studies that reported the inclusion of:</p> <p> <ul id="CD001751-list-0004"> <li> <p>women with secondary dysmenorrhoea (with identified pathology from a physical examination);</p> </li> <li> <p>women with irregular/infrequent menstrual cycles (outside of the typical range of a 21‐ to 35‐day cycle); </p> </li> <li> <p>women using an intrauterine contraceptive device (IUCD);</p> </li> <li> <p>pregnant or breastfeeding women.</p> </li> </ul> </p> </section> </section> <section id="CD001751-sec-0037"> <h4 class="title">Types of interventions</h4> <section id="CD001751-sec-0038"> <h5 class="title">Included comparisons</h5> <p> <ul id="CD001751-list-0005"> <li> <p>NSAIDs versus placebo</p> </li> <li> <p>NSAIDs versus NSAIDs (i.e. comparing one type of NSAID against another type of NSAID)</p> </li> <li> <p>NSAIDs versus paracetamol</p> </li> </ul> </p> <p>We considered differing doses and routes of administration of NSAIDs (oral and suppository).</p> <p>We categorised NSAIDs as non‐selective or as COX‐2‐specific inhibitors based on US Food and Drug Administration categories (<a href="./references#CD001751-bbs2-0219" title="USFood , DrugAdministration . COX‐2 selective (includes Bextra, Celebrex, and Vioxx) and non‐selective non‐steroidal anti‐inflammatory drugs (NSAIDs). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm429364.htm2015. ">FDA 2015</a>). </p> </section> </section> <section id="CD001751-sec-0039"> <h4 class="title">Types of outcome measures</h4> <section id="CD001751-sec-0040"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001751-list-0006"> <li> <p>Pain relief ‐ measured with a visual analogue scale (VAS) (i.e. a measure of the amount of pain relief on a 1 to 10 scale) or as dichotomous data (i.e. at least moderate pain relief versus no pain relief). </p> </li> </ul> </p> <p>If other scales or labels were used, we collapsed these (if possible) into dichotomous data, based on the authors' descriptions of the scale, so that women experiencing 'at least moderate' pain relief were reported as having pain relief, whereas women with only mild pain relief were reported as having no pain relief. If pain intensity was reported rather than pain relief we also considered this and recorded it as a separate outcome. We reported continuous data if dichotomous data could not be extracted. </p> <p> <ul id="CD001751-list-0007"> <li> <p>Adverse effects:</p> <ul id="CD001751-list-0008"> <li> <p>Total number of adverse effects ('all')</p> </li> <li> <p>Gastrointestinal adverse effects (for example, nausea, vomiting)</p> </li> <li> <p>Neurological (nervous system) adverse effects (for example, headache, fatigue, dizziness).</p> </li> </ul> </li> </ul> </p> </section> <section id="CD001751-sec-0041"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001751-list-0009"> <li> <p>Requirement for additional medication</p> </li> <li> <p>Interference with daily activities</p> </li> <li> <p>Absence from work or school</p> </li> </ul> </p> </section> </section> </section> <section id="CD001751-sec-0042"> <h3 class="title">Search methods for identification of studies</h3> <p>We searched for all randomised controlled trials of NSAIDs used to treat dysmenorrhoea, using the search strategy described below and in consultation with the Cochrane Menstrual Disorders and Subfertility Group (MDSG) Trials Search Co‐ordinator. There was no restriction by language or publication status. It is the intention of the review authors that a new search for RCTs be performed every two years and the review be updated accordingly. </p> <section id="CD001751-sec-0043"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases, trial registers and websites from inception to 7 January 2015: </p> <p> <ul id="CD001751-list-0010"> <li> <p>Cochrane Menstrual Disorders and Subfertility Group (MDSG) Specialised Register of controlled trials; </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, November 2014);</p> </li> <li> <p>MEDLINE;</p> </li> <li> <p>EMBASE;</p> </li> <li> <p>PsycINFO;</p> </li> <li> <p>CINAHL.</p> </li> </ul> </p> <p>We combined the MEDLINE search with the Cochrane highly sensitive search strategy for identifying randomised trials, which appears in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Version 5.1.0 chapter 6, 6.4.11 (<a href="./references#CD001751-bbs2-0223" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>)). We combined the EMBASE, PsycINFO and CINAHL searches with trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (<a href="http://www.sign.ac.uk/methodology/filters.html%23random" target="_blank">http://www.sign.ac.uk/methodology/filters.html#random</a>). </p> <p>Other electronic sources of trials included:</p> <p> <ul id="CD001751-list-0011"> <li> <p>trial registers for ongoing and registered trials:</p> <ul id="CD001751-list-0012"> <li> <p><a href="http://clinicaltrials.gov/ct2/home" target="_blank">http://www.clinicaltrials.gov</a> (a service of the US National Institutes of Health); </p> </li> <li> <p><a href="http://www.who.int/trialsearch/Default.aspx" target="_blank">http://www.who.int/trialsearch/Default.aspx</a> (the World Health Organization International Clinical Trials Registry Platform (ICTRP) search portal); </p> </li> </ul> </li> <li> <p>DARE (Database of Abstracts of Reviews of Effects) in <i>The Cochrane Library</i> at <a href="http://onlinelibrary.wiley.com/o/cochrane/cochrane_cldare_articles_fs.html" target="_blank">http://onlinelibrary.wiley.com/o/cochrane/cochrane_cldare_articles_fs.html</a> (for reference lists from relevant non‐Cochrane reviews); </p> </li> <li> <p>Web of Science (another source of trials and conference abstracts) to cross‐link citations of relevant articles; </p> </li> <li> <p>OpenGrey (<a href="http://www.opengrey.eu/" target="_blank">http://www.opengrey.eu/</a>) for unpublished literature from Europe; </p> </li> <li> <p>LILACS database (<a href="http://regional.bvsalud.org/php/index.php?lang=en" target="_blank">http://regional.bvsalud.org/php/index.php?lang=en</a>) for trials from the Portuguese and Spanish‐speaking world; </p> </li> <li> <p>PubMed; and</p> </li> <li> <p>Google (for recent trials not yet indexed in MEDLINE).</p> </li> </ul> </p> </section> <section id="CD001751-sec-0044"> <h4 class="title">Searching other resources</h4> <p>Wee also searched reference lists of relevant publications, review articles, abstracts of major scientific meetings and included studies. </p> </section> </section> <section id="CD001751-sec-0045"> <h3 class="title" id="CD001751-sec-0045">Data collection and analysis</h3> <section id="CD001751-sec-0046"> <h4 class="title">Selection of studies</h4> <p>One review author scanned the titles and abstracts of articles retrieved by the search and removed those that were very clearly irrelevant. We retrieved the full text of all potentially eligible studies. Two review authors independently examined the full‐text articles for compliance with the inclusion criteria and selected studies eligible for inclusion in the review. We attempted to contact study investigators as required, to clarify study eligibility (for example, with respect to randomisation). We resolved disagreements as to study eligibility by consensus. We planned to consult a third review author (CF) if there was any ongoing disagreement; however this did not prove necessary. </p> <p>We documented the selection process with a PRISMA flow chart (<a href="#CD001751-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD001751-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001751-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001751-sec-0047"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (JM and either MP or RD) independently extracted data using a standardised form designed by the authors (<a href="#CD001751-fig-0002">Figure 2</a>). We resolved discrepancies by discussion. For each study, we extracted data on study design, participants, interventions and outcome measures: these are presented in the <a href="./references#CD001751-sec-0144" title="">Characteristics of included studies</a> table. We also extracted data on study findings: these are presented in the <a href="./full#CD001751-sec-0066">Results</a> and the <a href="./references#CD001751-sec-0127" title="">Data and analyses</a> sections. </p> <div class="figure" id="CD001751-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Data extraction form" data-id="CD001751-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Data extraction form</p> </div> </div> </div> <p>For the first version of this review, we made attempts to contact the authors of 29 trials published since 1985 in order to clarify aspects of methodology or obtain missing data. We received replies from eight authors or co‐authors of these trials. We did not make attempts to contact authors of studies published before 1985 or where no recent address for any of the authors could be found. Where studies had multiple publications, we used the most recent report. </p> <p>Where studies had multiple publications, we used the main trial report as the reference and derived additional details from secondary papers. The review authors collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review: such studies are grouped under a single study ID with multiple references. </p> </section> <section id="CD001751-sec-0048"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For this review update, two review authors (CF and JM) independently conducted assessment of risk of bias, using the Cochrane 'Risk of bias' assessment tool to evaluate all included studies for the following: adequacy of sequence generation and allocation concealment; adequacy of blinding of women, providers and outcome assessors; completeness of outcome data; risk of selective outcome reporting and risk of other potential sources of bias (<a href="./references#CD001751-bbs2-0223" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <section id="CD001751-sec-0049"> <h5 class="title">Sequence generation</h5> <p>We considered the following methods of random sequence generation adequate:</p> <p> <ul id="CD001751-list-0013"> <li> <p>referring to a random number table;</p> </li> <li> <p>using a computer random number generator;</p> </li> <li> <p>coin tossing;</p> </li> <li> <p>shuffling cards or envelopes;</p> </li> <li> <p>throwing dice;</p> </li> <li> <p>drawing of lots.</p> </li> </ul> </p> <p>We deemed the risk of bias low if one of these methods was described. We deemed the risk of bias unclear if the study was described as randomised but the sequence generation method was not described. </p> </section> <section id="CD001751-sec-0050"> <h5 class="title">Allocation concealment</h5> <p>We considered the following methods of allocation concealment adequate:</p> <p> <ul id="CD001751-list-0014"> <li> <p>central allocation, including telephone, web‐based and pharmacy‐controlled randomisation;</p> </li> <li> <p>sequentially numbered drug containers of identical appearance;</p> </li> <li> <p>sequentially numbered, opaque, sealed envelopes.</p> </li> </ul> </p> <p>We deemed the risk of bias low if one of these methods was described. We deemed the risk of bias unclear if the study was described as randomised but the method used for allocation concealment was not described. </p> </section> <section id="CD001751-sec-0051"> <h5 class="title">Blinding</h5> <p>Blinding refers to whether participants and study personnel knew which women were receiving active treatment and which were receiving placebo. We considered blinding adequate if any of the following were described: </p> <p> <ul id="CD001751-list-0015"> <li> <p>blinding of women and (specified) key study personnel, provided it appeared unlikely that the blinding could have been broken; </p> </li> <li> <p>use of identical placebo;</p> </li> <li> <p>unblinding of study personnel at the end of the study.</p> </li> </ul> </p> <p>We deemed the risk of bias low if one of these methods was described. We deemed the risk of bias unclear if the study was described as blinded but no further details were reported. As noted above, we excluded studies that were clearly not blinded. </p> </section> <section id="CD001751-sec-0052"> <h5 class="title">Attrition bias</h5> <p>We considered outcome data as complete if either of the following applied:</p> <p> <ul id="CD001751-list-0016"> <li> <p>all women randomised were analysed;</p> </li> <li> <p>data were imputed for those missing.</p> </li> </ul> </p> <p>We deemed the risk of bias low if over 95% of randomised women were included in analysis, unclear if 90% to 95% of randomised women were included in analysis and high if less than 90% of randomised women were included in analysis. As noted above, we excluded studies that clearly analysed less than 80% of randomised women for at least one of the primary outcomes. </p> </section> <section id="CD001751-sec-0053"> <h5 class="title">Selective reporting</h5> <p>We assessed a study as being free of the risk of selective outcome reporting if both the following applied: </p> <p> <ul id="CD001751-list-0017"> <li> <p>the published report included all expected outcomes;</p> </li> <li> <p>outcomes were reported systematically for all comparison groups, based on prospectively collected data. </p> </li> </ul> </p> <p>We deemed the risk of bias low if both of the criteria were met, unclear if these criteria were not met and high if there was evidence that data had been collected on outcomes of interest but were not reported in the study publication. </p> </section> <section id="CD001751-sec-0054"> <h5 class="title">Potential bias related to study funding</h5> <p>We assessed a study as being at unclear risk of bias related to study funding if it was commercially sponsored or the source of funding was not reported </p> <p>We resolved disagreements by consensus. The results of the assessment of risk of bias are presented in the <a href="./references#CD001751-sec-0144" title="">Characteristics of included studies</a> and in a summary table (<a href="#CD001751-fig-0003">Figure 3</a>). We incorporated these results into the interpretation of review findings by means of sensitivity analyses. </p> <div class="figure" id="CD001751-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD001751-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> </section> </section> <section id="CD001751-sec-0055"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. numbers reporting relief of pain), we calculated log odds ratios and their standard errors, and entered these in tables using the generic inverse variance option in RevMan (<a href="./references#CD001751-bbs2-0235" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), where they were displayed as odds ratios and 95% confidence intervals. </p> <p>For continuous data (e.g. pain scores), we calculated mean differences and their standard errors and entered these in tables using the generic inverse variance option, where they were displayed as mean differences with 95% confidence intervals. </p> </section> <section id="CD001751-sec-0056"> <h4 class="title">Unit of analysis issues</h4> <section id="CD001751-sec-0057"> <h5 class="title">Denominator</h5> <p>We only included data reported 'per woman' in meta‐analyses. Where studies reported data only 'per menstrual cycle' we briefly summarised results in an additional table. Where trials compared two NSAIDs against placebo, if possible we evenly divided the placebo group between the two trials to avoid double‐counting in the meta‐analysis. Where the placebo group contained an uneven number of women, we entered the placebo group for both comparisons and performed a sensitivity analysis to examine the effect on pooled findings. </p> </section> <section id="CD001751-sec-0058"> <h5 class="title">Cross‐over trials</h5> <p>For the 2009 update of this review (and subsequent updates) we made an a priori decision to include data from all phases of cross‐over trials, wherever possible. The strength of a cross‐over design is that variation in repeated responses between women is usually less than that between different women and hence the trials can give more precise results. To exploit this correlation, cross‐over trials should be analysed using a method of analysis specific to paired data. Methods are now available for meta‐analysing cross‐over trials and for combining the summary effect measures of parallel and cross‐over trials. However, to date the reporting of cross‐over trials has been very variable and the data required to include a paired analysis in a meta‐analysis are frequently unreported so that there is insufficient information to apply any one synthesis method consistently (<a href="./references#CD001751-bbs2-0217" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31:140‐9. ">Elbourne 2002</a>). </p> <p>In this review, where cross‐over trials were analysed using methods suitable for paired data and reported an overall measure of effect and standard error (or where this was calculable), we extracted these data and displayed them alongside data from parallel trials. Where cross‐over trials reported dichotomous data or continuous data analysed using non‐paired methods, we extracted these data as if they derived from parallel trials (i.e. as if they had twice as many women). This method of analysis permits the use of more of the available data but is likely to widen confidence intervals, with the possible consequence of disguising clinically important heterogeneity (differences between the studies). Nevertheless, this incorrect analysis is conservative, in that studies are under‐weighted rather than over‐weighted. We explored the effect of this choice of analysis in sensitivity analyses. </p> </section> </section> <section id="CD001751-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>We only included analyses reported in the primary studies that included at least 80% of women in the review. </p> <p>We analysed data on an intention‐to‐treat basis as far as possible. Where data were missing, we made attempts to obtain them from the original investigators. Where they were unobtainable, we only analysed the available data, based on the numerator and denominator reported in study results or calculable from reported percentages. We explored the effect of excluding studies with more than 10% of data missing in sensitivity analyses. </p> </section> <section id="CD001751-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether the clinical and methodological characteristics of the included studies were sufficiently similar for meta‐analysis to provide a meaningful summary. Where pooling was conducted, we examined heterogeneity between the results of different studies by inspecting the scatter in the data points and the overlap in their confidence intervals and more formally by checking the results of the Chi<sup>2</sup> tests and I<sup>2</sup> statistic. We took a P value of less than 0.1 for the Chi<sup>2</sup> test to indicate significant heterogeneity and if this was detected, we used the I<sup>2</sup> statistic to estimate the percentage of the variability in effect estimates due to heterogeneity rather than sampling error. We took an I<sup>2</sup> value greater than 50% to indicate substantial heterogeneity (<a href="./references#CD001751-bbs2-0222" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>; <a href="./references#CD001751-bbs2-0223" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD001751-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty in detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert for duplication of data. We used a funnel plot to assess the possibility of small study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies) for the primary review outcomes. We cautiously considered visible asymmetry in the funnel plot as a possible indication of publication bias. </p> </section> <section id="CD001751-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We synthesised (combined) the data from primary studies if they were sufficiently homogeneous. We stratified studies by the type of NSAID and comparator used. </p> <p>For the 2009 update of the review (and subsequent updates including this one in 2015) we made an a priori decision to pool both cross‐over and parallel data using the inverse variance method. We calculated mean differences (MDs) for continuous data and pooled odds ratios for dichotomous data, with 95% confidence intervals. We used both fixed‐effect and random‐effects statistical models. Fixed‐effect models are displayed in the review where data are homogeneous. An increase in the odds of a particular outcome, which may be beneficial (for example, pain relief) or detrimental (for example, an adverse effect), is displayed graphically in the meta‐analyses to the right of the centre‐line and a decrease in the odds of an outcome to the left of the centre‐line. </p> <p>If it was not possible to extract from a trial report either dichotomous or continuous data suitable for the calculation of ORs or MDs then we reported statistical data in additional tables. Where trial results were presented only as graphs, we described the findings in the text. </p> <p>We translated the key results into assumed and comparative risks expressed as a percentage. We estimated control group risks for the main comparison from median values in the placebo group in 31 studies of pain relief and 19 of adverse effects in a previous version of this review, and we estimated the corresponding intervention group risk using the formula suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001751-bbs2-0223" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>; Section 11.5.5). </p> </section> <section id="CD001751-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to subgroup studies by the type of NSAID used (non‐selective or COX‐2‐specific inhibitors) if there were sufficient studies in each group that reported the same outcome (for example, three or more studies in each group). However, this was not done as we only included two studies of COX‐2‐selective inhibitors in the review. </p> <p>Where a visual scan of the forest plots or the results of statistical tests indicated substantial heterogeneity, we explored possible explanations in sensitivity analyses and/or in the text, and we tested the effect of using a random‐effects model. </p> <p>We planned to conduct subgroup analyses for primary outcomes only.</p> </section> <section id="CD001751-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We planned sensitivity analyses for the primary review outcomes to determine whether the results were robust to decisions made during the review process. </p> <p>These analyses excluded the following studies:</p> <p> <ul id="CD001751-list-0018"> <li> <p>studies that did not clearly describe adequate procedures for allocation concealment and blinding; </p> </li> <li> <p>studies with more than 10% of data missing or imputed for the primary outcomes;</p> </li> <li> <p>studies with a unit of analysis error (such as those in which cross‐over data were analysed as if they derived from parallel studies); </p> </li> <li> <p>studies that contributed twice to a pooled analysis: this occurred occasionally where a study contributed more than one comparison to a pooled analysis and either the numerator or the denominator in the placebo group were odd numbers. Where this occurred it was reported in the results for the relevant analysis. </p> </li> </ul> </p> <section id="CD001751-sec-0065"> <h5 class="title">Overall quality of the body of evidence: 'Summary of findings' table</h5> <p>We prepared a 'Summary of findings' table using the Guideline Development Tool software. This table evaluates the overall quality of the body of evidence for the primary review outcomes (pain relief and adverse effects), using GRADE criteria (study limitations (i.e. risk of bias), consistency of effect, imprecision, indirectness and publication bias). We incorporated judgements about evidence quality (high, moderate or low) into the reporting of results for each primary outcome. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001751-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001751-sec-0066"></div> <section id="CD001751-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD001751-sec-0068"> <h4 class="title">Results of the search</h4> <p>The search completed in January 2015 retrieved 497 records, of which we discarded 370 as clearly ineligible. We retrieved 18 articles for further assessment regarding their eligibility, 10 from databases (for which we obtained the full text) and eight from trial registers. JM and RA independently checked these 18 articles for eligibility. </p> <p>Out of these 18 articles, we newly included seven studies in the current (2015) update and we newly excluded 10 studies (11 articles). This gives a total of 80 included studies (seven newly included in 2015, plus 73 from the previous version of the review) and 127 excluded (10 newly excluded in 2015, plus 117 from the previous version of the review). See <a href="#CD001751-fig-0001">Figure 1</a>. </p> </section> <section id="CD001751-sec-0069"> <h4 class="title">Included studies</h4> <section id="CD001751-sec-0070"> <h5 class="title">Trial design and setting</h5> <p>The review includes 80 RCTs, 24 of parallel design and 56 of cross‐over design. They randomised a total of 5820 women, 2372 in parallel studies and 3448 in cross‐over studies. Sample size in the parallel trials ranged from 17 to 410; seven randomised over 100 women. Sample size in the cross‐over trials ranged from 11 to 198. </p> <p>The studies were conducted in the USA (n = 26 trials), Sweden (n = 9), Italy (n = 6), the UK (n = 5), Brazil, Finland, Mexico (n = 4 each), Iran, Norway, South Africa (n = 3 each), Canada, Nigeria, Spain (n = 2 each), Argentina, China, Colombia, Denmark, France, Germany and Iraq (n = 1 each). The majority were published in English, although five were in Spanish, four in Portuguese and one each in French, Italian and Norwegian. Trials were translated as required by members of The Cochrane Collaboration. </p> </section> <section id="CD001751-sec-0071"> <h5 class="title">Participants</h5> <p>The inclusion and exclusion criteria for the majority of included studies were quite explicit. All but three of the trials stated clearly either that they included only women with primary dysmenorrhoea, or that women with secondary dysmenorrhoea were excluded. The other three studies had less specific inclusion criteria that did not define dysmenorrhoea (<a href="./references#CD001751-bbs2-0001" title="AkerlundM , StrombergP . Comparison of ketoprofen and naproxen in the treatment of dysmenorrhoea, with special regard to the time of onset of pain relief. Current Medical Research &amp; Opinion1989;11:485‐90. StrombergP , AkerlundM . Pain relief in dysmenorrhea can be achieved more rapidly with ketoprofen than with naproxen [Snabbare smartlindring vid dysmenorre med ketoprofen an med naproxen]. Lakartidningen1990;87(4):191‐3. ">Akerlund 1989</a>; <a href="./references#CD001751-bbs2-0066" title="PaulsF . Naproxen in dysmenorrhea. Lancet1978;2:159‐60. ">Pauls 1978</a>), or included both primary and secondary dysmenorrhoea but reported results separately (<a href="./references#CD001751-bbs2-0189" title="SahinI , SaracogluF , KurbanY , TurkkaniB . Dysmenorrhea treatment with a single daily dose of rofecoxib. International Journal of Gynecology and Obstetrics2003;83:285‐91. ">Sahin 2003</a>). The diagnosis of primary dysmenorrhoea was confirmed by a physical or gynaecological examination in 40 of the included studies. Oral contraceptive use was an exclusion criterion in most of the studies, and other common exclusion criteria were pelvic disease, intrauterine device (IUD) use, irregular menstrual cycles, renal or hepatic disorders, contraindications to nonsteroidal anti‐inflammatory drugs, pregnancy, planned pregnancy and use of hormonal preparations, analgesics or other medications that could interfere with the proposed comparisons. </p> <p>Most studies detailed the demographic characteristics of the women. Their mean age ranged from 15.8 to 32.2 years (where stated). </p> </section> <section id="CD001751-sec-0072"> <h5 class="title">Interventions</h5> <p>Included comparisons eligible for the review were as follows:</p> <p> <ul id="CD001751-list-0019"> <li> <p>NSAID versus placebo: 56 trials;</p> </li> <li> <p>NSAID versus NSAID: 17 trials;</p> </li> <li> <p>NSAID versus NSAID versus placebo: four trials;</p> </li> <li> <p>NSAID versus paracetamol: one trial;</p> </li> <li> <p>NSAID versus paracetamol versus placebo: two trials.</p> </li> </ul> </p> <p>Eighteen different types of non‐selective NSAIDs were evaluated in the included studies: aceclofenac, aspirin, dexketoprofen, diclofenac, etodolac, fenoprofen, flufenamic acid, flurbiprofen, ibuprofen, indomethacin, ketoprofen, lysine clonixinate, mefenamic acid, meloxicam, naproxen, niflumic acid, nimesulide and piroxicam. </p> <p>Only two types of COX‐2‐specific NSAIDs were evaluated: celecoxib and etoricoxib. Several of the included studies reported data on comparison arms receiving interventions not relevant to this review (e.g. NSAIDs that have been withdrawn by the manufacturers, mild opiate analgesics as a comparison, herbal interventions); we excluded such data from analysis. </p> <p>Doses of NSAIDs varied, but fell within commonly recommended parameters. Average doses for non‐selective NSAIDs were as follows: aceclofenac (100 mg daily), aspirin (650 mg; four‐hourly), dexketoprofen (12.5 mg to 25 mg; six‐hourly), diclofenac (up to 200 mg daily in divided doses, orally or by suppository), etodolac (200 mg to 300 mg twice daily), fenoprofen (100 mg to 200 mg; four‐hourly), fentiazac (100 mg; twice daily), flufenamic acid (200 mg; eight‐hourly), flurbiprofen (100 mg; twice daily), ibuprofen (400 mg; three, four or six times daily), indomethacin (25 mg tablets or 100 mg suppositories; three times daily), ketoprofen (25 mg to 50 mg; six‐hourly, with or without a loading dose of 25 mg to 70 mg), lysine clonixinate (125 mg; six‐hourly); meclofenamate sodium (100 mg; eight‐hourly), mefenamic acid (250 mg; eight‐hourly), meloxicam (7.5 mg to 15 mg; daily), daily naproxen/naproxen sodium (250 mg to 275 mg; four to eight‐hourly, sometimes with a loading dose of 500 mg to 550 mg), niflumic acid (250 mg; three times daily), nimesulide (50 mg to 100 mg twice daily), piroxicam (20 to 40 mg daily, by tablet or suppository) and tolfenamic acid (200 mg; eight‐hourly). Doses of COX‐2‐specific inhibitors used were: celecoxib: 400 mg then 200 mg 12‐hourly and etoricoxib 120 mg daily. </p> <p>The duration of treatment in the included studies varied from one cycle (per treatment) to five. For details of the drug regimes used in individual studies, see the <a href="./references#CD001751-sec-0144" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD001751-sec-0073"> <h5 class="title">Outcomes</h5> <p>Outcomes measures varied. Most studies measured pain relief by asking women to keep a daily record during their menstrual period, rating their degree of pain relief on an ordinal scale, either categorical (e.g. from poor to excellent) or numerical (e.g. 1 to 5), while others used a dichotomous measure (e.g. complete relief/ongoing pain). Some women were asked to rate their pain intensity on various types of continuous numerical scale: few studies used a visual analogue scale. In most cases pain relief was reported as the proportion of women experiencing relief, though some trials instead used the number of menstrual cycles as the denominator. Interference with daily activities and absence from work/school were generally measured as the proportion of women reporting any degree of interference with their normal routine or any need for days off. About a quarter of the trials clearly reported that they measured adverse effects by prospective self report, using a questionnaire, record card or diary in which the women noted any symptoms daily during their menstrual period. Others assessed this outcome retrospectively at follow‐up appointments, by either specific or non‐specific questioning or simply by recording information volunteered by the participant. Many trials did not specify how they measured adverse effects. </p> </section> </section> <section id="CD001751-sec-0074"> <h4 class="title">Excluded studies</h4> <p>In total we excluded 127 trials from the review, for the following reasons:</p> <p> <ul id="CD001751-list-0020"> <li> <p>35 trials did not mention randomisation, included non‐randomised women in analysis, or their design was unclear and attempts to contact authors for clarification were unsuccessful; </p> </li> <li> <p>14 trials were randomised but had only single blinding or no blinding at all;</p> </li> <li> <p>12 trials included NSAIDs that are currently discontinued (for the treatment of dysmenorrhoea) and did not report data on any other relevant comparison; </p> </li> <li> <p>19 trials included women who had secondary dysmenorrhoea (including IUCD‐related dysmenorrhoea), menorrhagia or eumenorrhoea; </p> </li> <li> <p>three trials measured uterine pressure or contractibility rather than pain relief;</p> </li> <li> <p>13 trials did not include a comparison of interest;</p> </li> <li> <p>five trials were dose‐finding trials of a single NSAID;</p> </li> <li> <p>26 trials had participant withdrawal rates of 20% or more.</p> </li> </ul> </p> <p>See <a href="./references#CD001751-sec-0145" title="">Characteristics of excluded studies</a> for more information. </p> </section> </section> <section id="CD001751-sec-0075"> <h3 class="title">Risk of bias in included studies</h3> <p>The quality of the included studies is summarised in <a href="#CD001751-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD001751-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study." data-id="CD001751-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <section id="CD001751-sec-0076"> <h4 class="title">Allocation</h4> <p>All studies stated that they were randomised, but only 23% (18/80) described in detail their method of generating a random allocation sequence. We rated these studies as at low risk of bias, while we rated all the other studies as at unclear risk. </p> <p>Less than 12% of studies (9/80) described an adequate method of allocation concealment. We rated these studies as at low risk of bias, while we rated all the other studies as at unclear risk. </p> </section> <section id="CD001751-sec-0077"> <h4 class="title">Blinding</h4> <p>All studies were described as double‐blinded, and 50 studies (50/80: 63%) provided details of who was blinded or stated explicitly that the placebo was identical to the active treatment. Given the subjective nature of the pain‐related outcomes assessed in this review, inadequate blinding has a high potential to bias results. We rated the other 30 studies as at unclear risk of bias. </p> </section> <section id="CD001751-sec-0078"> <h4 class="title">Incomplete outcome data</h4> <p>None of the included studies clearly analysed fewer than 80% of women randomised.</p> <p>Thirty‐one of the studies (39%) included over 95% of women randomised in analysis for one of our primary outcomes. We rated these as at low risk of attrition bias. Twenty‐seven studies (34%) included 90% to 95% of women in analysis and we rated them as at unclear risk of bias, while the other 22 studies included fewer than 90% of women in analysis, and we rated them as at high risk of bias. </p> <p>The main reasons for incomplete outcome data (where stated) were as follows: failure to attend follow‐up appointments, poor compliance with the study criteria, and withdrawal from treatment due to adverse effects, pregnancy, lack of efficacy, or wish to use contraceptives such as the oral contraceptive pill (OCP) or IUCD that were excluded by the trial criteria. Losses to follow‐up are likely to be associated with treatment inefficacy or adverse effects, and so have a high potential to bias results. </p> </section> <section id="CD001751-sec-0079"> <h4 class="title">Selective reporting</h4> <p>Only 24/80 studies (30%) clearly appeared to be free of selective reporting. In most studies (44/80; 55%) it was unclear whether data on adverse effects were collected prospectively. We rated nine studies as at high risk of selective reporting bias because adverse events were not reported as an outcome or it was clear that they were reported selectively. The impact of selective reporting of harms on the pooled result is not obvious, as selective emphasis of those adverse events where analyses were statistically significant might overstate those harms, and selective omission might attenuate the estimated effect (see <a href="./references#CD001751-sec-0144" title="">Characteristics of included studies</a>). </p> <section id="CD001751-sec-0080"> <h5 class="title">Potential bias related to study funding</h5> <p>Seven studies (7/80; 9%) reported a non‐commercial source of funding and we rated them as at low risk of potential bias related to study funding. We rated the other studies as at unclear risk of such bias: 47/80 studies (59%) were co‐authored or funded by pharmaceutical companies and 25/80(31%) did not mention their source of funding. </p> <p><b>Glossary</b> </p> <p>Please refer to the Cochrane glossary for explanation of unfamiliar terms: <a href="http://community.cochrane.org/glossary" target="_blank">http://community.cochrane.org/glossary</a>. </p> </section> </section> </section> <section id="CD001751-sec-0081"> <h3 class="title" id="CD001751-sec-0081">Effects of interventions</h3> <p>See: <a href="./full#CD001751-tbl-0001"><b>Summary of findings for the main comparison</b> NSAIDs compared to placebo for dysmenorrhoea</a>; <a href="./full#CD001751-tbl-0002"><b>Summary of findings 2</b> NSAIDs compared to paracetamol for dysmenorrhoea</a> </p> <section id="CD001751-sec-0082"> <h4 class="title">Pain relief</h4> <section id="CD001751-sec-0083"> <h5 class="title">1) Nonsteroidal anti‐inflammatory drugs (NSAIDs) versus placebo</h5> <p>There were 47 trials comparing NSAIDs versus placebo from which data on pain relief could be extracted, which were suitable for meta‐analysis. They compared the following NSAIDs versus placebo: aspirin (one study), celecoxib (two studies), diclofenac (three studies), etodolac (one study), etoricoxib (one study), fenoprofen (two studies), flufenamic acid (one study), ibuprofen (six studies), indomethacin (three studies), ketoprofen (two studies), lysine clonixinate (one study), mefenamic acid (four studies), meloxicam (one study), naproxen (21 studies), niflumic acid (one study) and nimesulide (two studies); some trials included more than one comparison. The studies analysed a total of 2602 women, 2006 women in cross‐over trials and 596 women in parallel trials. </p> <p>When we pooled dichotomous data from 35 studies comparing all NSAIDs versus placebo, NSAIDs were more effective than placebo at producing moderate or excellent pain relief (odds ratio (OR) 4.37, 95% confidence interval (CI) 3.76 to 5.09; I<sup>2</sup> = 53%) (<a href="./references#CD001751-fig-0007" title="">Analysis 1.1</a>; <a href="#CD001751-fig-0005">Figure 5</a>). Effect sizes varied, with few studies and wide confidence intervals for most comparisons. The most precise finding was for naproxen (OR 3.67, 95% CI 2.94 to 4.58; 16 studies, I<sup>2</sup> = 52%). The placebo groups in three studies contributed twice to the pooled analysis of all NSAIDs, but sensitivity analyses excluding these studies did not materially affect the results (<a href="./references#CD001751-bbs2-0027" title="DiGirolamoG , GimenoMAF , FalettiA , De LosSantosAR , MartiML , ZmijanovichR . Menstrual prostaglandins and dysmenorrhea: modulation by non‐steroidal antiinflammatory drugs [Prostaglandinas menstruales y dismenorrea su modulacion por antiinflamatorios no esteroideos]. Medicina1999;59:259‐64. ">Di Girolamo 1999</a>; <a href="./references#CD001751-bbs2-0050" title="MarchiniM , RozziL , BakshiR , PistaiR , FedeleL . Comparative study of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double‐blind, within‐patient, placebo‐controlled study. International Journal of Clinical Pharmacology &amp; Therapeutics1995;33:491‐7. ">Marchini 1995</a>; <a href="./references#CD001751-bbs2-0051" title="MehlischDR . Double‐blind crossover comparison of ketoprofen, naproxen and placebo in patients with primary dysmenorrhea. Clinical Therapeutics1990;12:398‐409. ">Mehlisch 1990</a>). Heterogeneity in these analyses is discussed below. </p> <div class="figure" id="CD001751-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data." data-id="CD001751-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data. </p> </div> </div> </div> <p>Among 12 studies reporting continuous data for this outcome, only two used visual analogue scales (VAS). The other 10 studies compared seven different NSAIDs versus placebo, using five different pain scales. We combined the studies that used common scales, as an attempt to pool scales (and calculate the standardised mean difference (SMD)) resulted in high levels of heterogeneity. In most analyses NSAIDs were more effective than placebo in producing moderate/excellent pain relief and/or in reducing pain scores. The only NSAIDs without clear indication of benefit were aspirin and fenoprofen, which were tested in a single study each (<a href="./references#CD001751-fig-0012" title="">Analysis 1.6</a>). </p> <p>Effect estimates for continuous outcomes of effectiveness were as follows:</p> <p> <ul id="CD001751-list-0021"> <li> <p>Diclofenac versus placebo (difference in improvement on a 0 to 100 VAS): mean difference (MD) 65.96, 95% CI 55.70 to 76.22, two studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0008" title="">Analysis 1.2</a>). </p> </li> <li> <p>Meloxicam versus placebo (difference in improvement on a 0 to 100 VAS): MD 34, 95% CI 15.88 to 52.12, one study (<a href="./references#CD001751-fig-0008" title="">Analysis 1.2</a>). </p> </li> <li> <p>Celecoxib, etoricoxib or naproxen versus placebo (mean difference in total pain relief using a time‐weighted scale (TOPAR)): MD 6.24, 95% CI 4.69 to 7.78, four studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0009" title="">Analysis 1.3</a>). </p> </li> <li> <p>Flufenamic acid or indomethacin versus placebo (difference in final score on a repeated 0 to 3 scale): MD 4.83, 95% CI 3.61 to 6.06, two studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0010" title="">Analysis 1.4</a>). </p> </li> <li> <p>Indomethacin versus placebo (difference in final score on a 0 to 18 scale): MD 11.20, 95% CI 7.24 to 15.16, one study (<a href="./references#CD001751-fig-0011" title="">Analysis 1.5</a>). </p> </li> <li> <p>Naproxen versus placebo (difference in final score on a 0 to 40 scale): MD 15.30, 95% CI 5.64 to 24.96, one study (<a href="./references#CD001751-fig-0011" title="">Analysis 1.5</a>). </p> </li> <li> <p>Aspirin or fenoprofen versus placebo (difference in pain intensity on a 0 to 4‐point scale): MD ‐0.33, 95% CI ‐0.84 to 0.18, two studies, I<sup>2</sup> = 36% (<a href="./references#CD001751-fig-0012" title="">Analysis 1.6</a>). </p> </li> <li> <p>Mefenamic acid versus placebo (difference in pain intensity on a 1 to 4 scale): MD ‐1.70, 95% CI ‐3.37 to ‐0.03 (<a href="./references#CD001751-fig-0013" title="">Analysis 1.7</a>). </p> </li> </ul> <ul id="CD001751-list-0022"> <li> <p>Naproxen versus placebo (difference in final score on a 0 to 40 scale): MD 15.30, 95% CI 5.64 to 24.96, one study (<a href="./references#CD001751-fig-0011" title="">Analysis 1.5</a>). </p> </li> <li> <p>Aspirin or fenoprofen versus placebo (difference in pain intensity on a 0 to 4‐point scale): MD ‐0.33, 95% CI ‐0.84 to 0.18, two studies, I<sup>2</sup> = 36% (<a href="./references#CD001751-fig-0012" title="">Analysis 1.6</a>). </p> </li> <li> <p>Mefenamic acid versus placebo (difference in pain intensity on a 1 to 4 scale): MD ‐1.70, 95% CI ‐3.37 to ‐0.03 (<a href="./references#CD001751-fig-0013" title="">Analysis 1.7</a>). </p> </li> </ul> </p> <p>A further 16 trials reported results on this outcome in a form from which no data suitable for meta‐analysis could be extracted, such as graphs (<a href="./references#CD001751-bbs2-0005" title="ArnoldJD , IberFL , BurtRA , GruberCM . Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea. Journal of Medicine1983;14:337‐50. ">Arnold 1983</a>; <a href="./references#CD001751-bbs2-0010" title="CashHC , HumpstomD , KasapHS . Feldene in the symptomatic treatment of primary dysmenorrhoea. Practitioner1982;22:1338‐41. ">Cash 1982</a>; <a href="./references#CD001751-bbs2-0014" title="CostaS , MioliM , RavaioliR , BufalinoL , GardiniF . Prostaglandin synthetase inhibitor piroxicam beta‐cyclodextrin in the treatment of primary dysmenorrhea. Current Therapeutic Research1987;42(1):156‐64. ">Costa 1987a</a>; <a href="./references#CD001751-bbs2-0037" title="IacovidesS , AvidonI , BentleyA , BakerFC . The 24‐h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized,double‐blinded, placebo‐controlled crossover study. Archives of Gynecology and Obstetrics2014;289(5):993‐1002. ">Iacovides 2014</a>; <a href="./references#CD001751-bbs2-0044" title="KintighJW . A multicenter, randomized, double‐blind, placebo controlled study of diclofenac potassium versus naproxen sodium in the treatment of primary dysmenorrhea. Today's Therapeutic Trends1995;12 Suppl(1):47‐61. ">Kintigh 1995</a>; <a href="./references#CD001751-bbs2-0047" title="LetzelH , MegardY , LamarcaR , RaberA , ForteaJ . The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea. European Journal of Obstetrics and Gynaecology and Reproductive Biology2006;129:162‐8. ">Letzel 2006</a>), as continuous data without standard deviations (<a href="./references#CD001751-bbs2-0057" title="MoggianG , PellegriE , TamburiniE , PiniP , TunideiU . A new pharmacologic treatment of primary dysmenorrhea [Un nuova trattamento farmacologico nella dismenorrea enenziale]. Clinica Terapeutica1986;117:481‐92. ">Moggian 1986</a>; <a href="./references#CD001751-bbs2-0065" title="PasqualeSA , RathauserR , DoleseHM . A double‐blind, placebo‐controlled study comparing three single‐dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea. American Journal of Medicine1988;84:30‐4. ">Pasquale 1988</a>; <a href="./references#CD001751-bbs2-0073" title="SaltveitT . Piroxicam in primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica1985;68:635‐7. SaltveitT . Piroxicam in primary dysmenorrhoea (Abstract). Archives of Gynecology1985;237:206. ">Saltveit 1985</a>), without denominators for each group (<a href="./references#CD001751-bbs2-0029" title="EzcurdiaM , Javier CortejosoF , LanzonR , Javier UgaldeF , HerruzoA , ArtigasR , et al. Comparison of the efficacy and tolerability of dexketoprofen and ketoprofen in the treatment of primary dysmenorrhoea. Journal of Clinical Pharmacology1998;38:65S‐73S. ">Ezcurdia 1998</a>; <a href="./references#CD001751-bbs2-0064" title="OsinusiBO , BamgboyeEA . Piroxicam in the symptomatic treatment of primary dysmenorrhea. Current Therapeutic Research1986;39(5):715‐8. ">Osinusi 1986</a>), or as per‐cycle data (<a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a>; <a href="./references#CD001751-bbs2-0053" title="MehlischDRD , ArdiaA , PallottaT . Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: a crossover trial. Current Therapeutic Research2003;64(6):327‐37. ">Mehlisch 2003</a>; <a href="./references#CD001751-bbs2-0069" title="PulkkinenMO . Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide. Journal of Clinical Pharmacology1987;27:65‐9. ">Pulkkinen 1987</a>; <a href="./references#CD001751-bbs2-0070" title="RiihiluomaP , WuolijokiE , PulkkinenMO . Treatment of primary dysmenorrhea with diclofenac sodium. European Journal of Obstetrics, Gynecology &amp; Reproductive Biology1981;12:189‐94. ">Riihiluoma 1981</a>; see <a href="#CD001751-tbl-0003">Table 1</a>) or as medians (<a href="./references#CD001751-bbs2-0061" title="NahidK , FariborzM , AtaolahG , SolokianS . The effect on an Iranian herbal drug on primary dysmenorrhea: a clinical controlled trial. Journal of Midwifery and Women's Health2009;54:401‐4. ">Nahid 2009</a>; see <a href="#CD001751-tbl-0004">Table 2</a>). They compared the following NSAIDs versus placebo: aspirin, diclofenac, fenoprofen, ibuprofen, indomethacin, mefenamic acid, naproxen, nimesulide and piroxicam. All NSAIDs were more effective than placebo, apart from aspirin, for which there was no evidence of a difference from placebo (<a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a>). </p> <div class="table" id="CD001751-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Pain relief: NSAIDs versus placebo (per cycle data)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where treatment gave moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13/89</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Indomethacin versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles when women reported moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nimesulide versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0069" title="PulkkinenMO . Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide. Journal of Clinical Pharmacology1987;27:65‐9. ">Pulkkinen 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where women rated therapy good/very effective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22/28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.01</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diclofenac versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0070" title="RiihiluomaP , WuolijokiE , PulkkinenMO . Treatment of primary dysmenorrhea with diclofenac sodium. European Journal of Obstetrics, Gynecology &amp; Reproductive Biology1981;12:189‐94. ">Riihiluoma 1981</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles when pain much improved</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14/58</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/57</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.05</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </div> <div class="table" id="CD001751-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pain relief: NSAIDs versus placebo: median data</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>P value</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Finding</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mefenamic acid versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0061" title="NahidK , FariborzM , AtaolahG , SolokianS . The effect on an Iranian herbal drug on primary dysmenorrhea: a clinical controlled trial. Journal of Midwifery and Women's Health2009;54:401‐4. ">Nahid 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (106 analysed)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain score: median (range)</p> <p>on 1 to 10 VAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n = 55</p> <p>At 2 months: 3.6 (2 to 6)</p> <p>At 3 months: 2.4 (1 to 5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n = 51</p> <p>At 2 months: 5 (2 to 6)</p> <p>At 3 months: 6 (4 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours NSAID</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </div> </section> <section id="CD001751-sec-0084"> <h5 class="title">2) NSAIDs versus NSAIDs</h5> <p>There were 18 studies comparing NSAIDs head‐to‐head from which data suitable for meta‐analysis could be extracted, only two of which compared the same two NSAIDs (<a href="./references#CD001751-bbs2-0019" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009a</a>; <a href="./references#CD001751-bbs2-0020" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009b</a>). They made the following comparisons: aspirin versus fenoprofen (<a href="./references#CD001751-fig-0021" title="">Analysis 2.1</a>); diclofenac versus the following: meloxicam (<a href="./references#CD001751-fig-0037" title="">Analysis 6.2</a>), ibuprofen and nimesulide (<a href="./references#CD001751-fig-0036" title="">Analysis 6.1</a>); ibuprofen versus the following: piroxicam, etoricoxib and lysine clonixinate (<a href="./references#CD001751-fig-0028" title="">Analysis 4.1</a>), mefenamic acid versus the following: meloxicam (<a href="./references#CD001751-fig-0032" title="">Analysis 5.1</a>) and tolfenamic acid; and naproxen versus the following: celecoxib (two studies), diclofenac, ketoprofen, etoricoxib, flurbiprofen, ibuprofen and piroxicam (<a href="./references#CD001751-fig-0041" title="">Analysis 7.1</a> to <a href="./references#CD001751-fig-0045" title="">Analysis 7.5</a>). </p> <p>In single studies, diclofenac reduced pain on a visual analogue 100‐point scale more than meloxicam (<a href="./references#CD001751-fig-0037" title="">Analysis 6.2</a>), fenoprofen reduced pain intensity more than aspirin (<a href="./references#CD001751-fig-0021" title="">Analysis 2.1</a>) and etoricoxib was more likely to achieve pain relief than ibuprofen (<a href="./references#CD001751-fig-0029" title="">Analysis 4.2</a>). Naproxen reduced pain scores more than ibuprofen or celecoxib (<a href="./references#CD001751-fig-0043" title="">Analysis 7.3</a>) and was more likely to achieve effective pain relief than ketoprofen (<a href="./references#CD001751-fig-0045" title="">Analysis 7.5</a>). Other head‐to‐head comparisons between NSAIDs showed no evidence of a difference between them. </p> <p>Effect estimates for all these comparisons were as follows:</p> <p> <ul id="CD001751-list-0023"> <li> <p>Aspirin versus fenoprofen (difference in pain intensity on a 0 to 3‐point scale): MD 0.65, 95% CI 0.10 to 1.20, one study (<a href="./references#CD001751-fig-0021" title="">Analysis 2.1</a>). </p> </li> <li> <p>Ibuprofen versus piroxicam or lysine clonixinate (rate of pain relief): OR 0.94, 95% CI 0.55 to 1.61 (<a href="./references#CD001751-fig-0028" title="">Analysis 4.1</a>). </p> </li> <li> <p>Ibuprofen versus etoricoxib (TOPAR 6): MD ‐0.89, 95% CI ‐1.74 to ‐0.04, one study (<a href="./references#CD001751-fig-0029" title="">Analysis 4.2</a>). </p> </li> <li> <p>Mefenamic acid versus meloxicam (rate of pain relief): OR 0.68, 95% CI 0.32 to 1.44, one study (<a href="./references#CD001751-fig-0032" title="">Analysis 5.1</a>). </p> </li> <li> <p>Mefenamic acid versus tolfenamic acid (10‐point VAS): MD 0.23, 95% CI ‐0.69 to 1.15, one study (<a href="./references#CD001751-fig-0033" title="">Analysis 5.2</a>). </p> </li> <li> <p>Diclofenac versus ibuprofen or nimesulide (rate of pain relief): OR 0.88, 95% CI 0.57 to 1.36, two studies, I<sup>2</sup> = 28% (<a href="./references#CD001751-fig-0036" title="">Analysis 6.1</a>). </p> </li> <li> <p>Diclofenac versus meloxicam (reduction on 100‐point VAS): MD 34, 95% CI 15.88 to 52.12 (<a href="./references#CD001751-fig-0037" title="">Analysis 6.2</a>). </p> </li> <li> <p>Naproxen versus ketoprofen or piroxicam (rate of pain relief): OR 0.65, 95% CI 0.36 to 1.17, two studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0041" title="">Analysis 7.1</a>). </p> </li> <li> <p>Naproxen versus flurbiprofen (sum of pain intensity difference over time: SPID): MD 0.06, 95% CI ‐0.28 to 0.40, one study (<a href="./references#CD001751-fig-0042" title="">Analysis 7.2</a>). </p> </li> <li> <p>Naproxen versus etoricoxib or celecoxib (mean difference on total pain relief using a time‐weighted scale (TOPAR8)): MD 2.44, 95% CI 0.83 to 4.06, two studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0043" title="">Analysis 7.3</a>). </p> </li> <li> <p>Naproxen versus ibuprofen or diclofenac (mean difference final score on a 1 to 5 scale): MD ‐0.17, 95% CI ‐0.39 to 0.06, two studies, I<sup>2</sup> = 51% (<a href="./references#CD001751-fig-0044" title="">Analysis 7.4</a>). </p> </li> <li> <p>Naproxen versus ketoprofen (difference in change scores on a 10‐point VAS): MD 1.10, 95% CI 0.56 to 1.64, one study (<a href="./references#CD001751-fig-0045" title="">Analysis 7.5</a>). </p> </li> </ul> </p> <p>Two additional studies reported only per‐cycle data. One found indomethacin more effective than aspirin (<a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a>), and one found no evidence of a difference between naproxen and diflunisal (<a href="./references#CD001751-bbs2-0042" title="KajanojaP . Difusinal compared with naproxen in the treatment of dysmenorrhea. Prostaglandins, Leukotrienes and Medicine1984;15:153‐8. ">Kajanoja 1984</a>) (<a href="#CD001751-tbl-0005">Table 3</a>). Twelve trials reported results on this outcome in such a way that no numerical data could be extracted. Some presented graphs (<a href="./references#CD001751-bbs2-0005" title="ArnoldJD , IberFL , BurtRA , GruberCM . Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea. Journal of Medicine1983;14:337‐50. ">Arnold 1983</a>; <a href="./references#CD001751-bbs2-0007" title="BenassiL , BertaniD , AvanziniA . An attempt at real prophylaxis of primary dysmenorrhea: comparison between meclofenamate sodium and naproxen sodium. Clinical &amp; Experimental Obstetrics &amp; Gynaecology1993;20:102‐7. ">Benassi 1993</a>; <a href="./references#CD001751-bbs2-0014" title="CostaS , MioliM , RavaioliR , BufalinoL , GardiniF . Prostaglandin synthetase inhibitor piroxicam beta‐cyclodextrin in the treatment of primary dysmenorrhea. Current Therapeutic Research1987;42(1):156‐64. ">Costa 1987a</a>; <a href="./references#CD001751-bbs2-0015" title="CostaS , MioliM , RavaioliR , BufalinoL , GardiniF . Prostaglandin synthetase inhibitor piroxicam beta‐cyclodextrin in the treatment of primary dysmenorrhea. Current Therapeutic Research1987;42(1):156‐64. ">Costa 1987b</a>; <a href="./references#CD001751-bbs2-0044" title="KintighJW . A multicenter, randomized, double‐blind, placebo controlled study of diclofenac potassium versus naproxen sodium in the treatment of primary dysmenorrhea. Today's Therapeutic Trends1995;12 Suppl(1):47‐61. ">Kintigh 1995</a>; <a href="./references#CD001751-bbs2-0067" title="Pedron NuevoDN . Treatment of primary dysmenorrhea. Comparative study of ibuprofen and mefenamic acid [Tratamiento de la dismenorrea primeria. Estudio comparativo de ibuprofen y acido mefenamico]. Ginecologica y Obstetricia de Mexico1995;63:4‐9. ">Pedron 1995</a>), or continuous data without standard deviations (<a href="./references#CD001751-bbs2-0065" title="PasqualeSA , RathauserR , DoleseHM . A double‐blind, placebo‐controlled study comparing three single‐dose regimens of piroxicam with ibuprofen in patients with primary dysmenorrhea. American Journal of Medicine1988;84:30‐4. ">Pasquale 1988</a>; <a href="./references#CD001751-bbs2-0074" title="SaltveitT . Piroxicam versus naproxen for primary dysmenorrhoea [Piroxicam versus naproxen ved primore dysmenore]. Tidskrift Norske Loegeforening1989;109(5):576‐8. ">Saltveit 1989</a>), while one did not provide denominators for each group (<a href="./references#CD001751-bbs2-0062" title="OnatraW , BautistaAA , CalisO . Double blind cross‐evaluation of effects and tolerance of etodolac versus piroxicam in the treatment of primary dysmenorrhea [Valoracion doble‐ciega cruzada de la eficacia y tolerancia de etodolac vs prioxicam en el tratamiento de la dismenorrea primaria]. Arquivos Brasileiros de Medicina1994;68:199‐202. ">Onatra 1994</a>). Only three of these trials reported differences between different NSAIDs: one trial found meclofenamate sodium more effective than naproxen (<a href="./references#CD001751-bbs2-0007" title="BenassiL , BertaniD , AvanziniA . An attempt at real prophylaxis of primary dysmenorrhea: comparison between meclofenamate sodium and naproxen sodium. Clinical &amp; Experimental Obstetrics &amp; Gynaecology1993;20:102‐7. ">Benassi 1993</a>), and two trials found piroxicam more effective than naproxen (<a href="./references#CD001751-bbs2-0014" title="CostaS , MioliM , RavaioliR , BufalinoL , GardiniF . Prostaglandin synthetase inhibitor piroxicam beta‐cyclodextrin in the treatment of primary dysmenorrhea. Current Therapeutic Research1987;42(1):156‐64. ">Costa 1987a</a>; <a href="./references#CD001751-bbs2-0015" title="CostaS , MioliM , RavaioliR , BufalinoL , GardiniF . Prostaglandin synthetase inhibitor piroxicam beta‐cyclodextrin in the treatment of primary dysmenorrhea. Current Therapeutic Research1987;42(1):156‐64. ">Costa 1987b</a>). However, these trials were very small (with 30, 12 and 14 women respectively) and much larger studies comparing piroxicam with naproxen found no evidence of a difference between them (<a href="./references#CD001751-bbs2-0074" title="SaltveitT . Piroxicam versus naproxen for primary dysmenorrhoea [Piroxicam versus naproxen ved primore dysmenore]. Tidskrift Norske Loegeforening1989;109(5):576‐8. ">Saltveit 1989</a>; <a href="./references#CD001751-bbs2-0078" title="WilhelmssonL , JonssonK , HallingL , HermannM , JaderlingJ , LindellC , et al. Piroxicam in the treatment of primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica1985;64:317‐21. ">Wilhelmsson 1985a</a>). </p> <div class="table" id="CD001751-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pain relief: NSAIDs versus NSAIDs (per cycle data)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 1</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 2</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 1</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 2</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Indomethacin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where treatment gave moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13/89</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diflunisal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0042" title="KajanojaP . Difusinal compared with naproxen in the treatment of dysmenorrhea. Prostaglandins, Leukotrienes and Medicine1984;15:153‐8. ">Kajanoja 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 (19 analysed)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where treatment achieved moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34/38</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28/38 cycles</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </div> </section> <section id="CD001751-sec-0085"> <h5 class="title">3) NSAIDs versus paracetamol</h5> <p>Two studies compared ibuprofen versus paracetamol and one compared naproxen versus paracetamol. Pooling of these three studies resulted in a difference in the proportion of women reporting good, excellent or complete pain relief, favouring NSAIDs over paracetamol (OR 1.89, 95% CI 1.05 to 3.43) (<a href="./references#CD001751-fig-0052" title="">Analysis 8.1</a>). </p> </section> </section> <section id="CD001751-sec-0086"> <h4 class="title">Adverse effects</h4> <section id="CD001751-sec-0087"> <h5 class="title">1) NSAIDs versus placebo</h5> <section id="CD001751-sec-0088"> <h6 class="title">All adverse effects</h6> <p>Twenty‐five studies were suitable for meta‐analysis for this outcome. They analysed 2133 women, 1272 in cross‐over studies and 861 in parallel‐group studies. They compared the following NSAIDs versus placebo: naproxen (10 studies), piroxicam (five studies), diclofenac, ibuprofen, ketoprofen (three studies each), celecoxib, fenoprofen (two studies each), aceclofenac, aspirin, dexketoprofen, etodolac, etoricoxib and niflumic acid and nimesulide (one study each). </p> <p>Although there was no evidence of a difference between any individual NSAID and placebo for this outcome, when we pooled results NSAIDs overall were more likely to cause an adverse effect of any kind than placebo (OR 1.29, 95% CI 1.11 to 1.51, 25 studies, I<sup>2</sup> = 0%) (<a href="./references#CD001751-fig-0015" title="">Analysis 1.9</a>). The most commonly reported adverse effects were mild neurological and gastrointestinal symptoms. The placebo groups in two studies contributed twice to the pooled analysis of all NSAIDs, but exclusion of these studies did not materially affect the results (<a href="./references#CD001751-bbs2-0019" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009a</a>; <a href="./references#CD001751-bbs2-0020" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009b</a>). </p> <p>Two additional cross‐over studies measured this outcome. One stated that no adverse events were reported in association with either diclofenac or placebo (<a href="./references#CD001751-bbs2-0037" title="IacovidesS , AvidonI , BentleyA , BakerFC . The 24‐h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized,double‐blinded, placebo‐controlled crossover study. Archives of Gynecology and Obstetrics2014;289(5):993‐1002. ">Iacovides 2014</a>); the other reported that no serious side effects occurred in association with either piroxicam or placebo (<a href="./references#CD001751-bbs2-0064" title="OsinusiBO , BamgboyeEA . Piroxicam in the symptomatic treatment of primary dysmenorrhea. Current Therapeutic Research1986;39(5):715‐8. ">Osinusi 1986</a>). </p> </section> <section id="CD001751-sec-0089"> <h6 class="title">Gastrointestinal adverse effects</h6> <p>Fourteen studies were suitable for meta‐analysis for this outcome, which included adverse effects such as nausea and indigestion. They analysed a total of 702 women, 548 in cross‐over studies and 154 in parallel‐group studies, and compared the following NSAIDs versus placebo: naproxen (four studies), indomethacin, piroxicam (three studies), aspirin, mefenamic acid (two studies each), dexketoprofen, fenoprofen and ketoprofen (one study each). When we pooled all studies, gastrointestinal events were more common in the NSAIDs group (OR 1.58, 95% CI 1.12 to 2.23) (<a href="./references#CD001751-fig-0016" title="">Analysis 1.10</a>). A higher incidence of gastrointestinal side effects was associated with two individual NSAIDs: naproxen (OR 2.30, 95% CI 1.02 to 5.19, four studies, I<sup>2</sup> = 1%) and dexketoprofen (OR 8.06, 95% CI 0.50 to 130.48). One additional study reported no events in either the piroxicam or the placebo arm (<a href="./references#CD001751-bbs2-0014" title="CostaS , MioliM , RavaioliR , BufalinoL , GardiniF . Prostaglandin synthetase inhibitor piroxicam beta‐cyclodextrin in the treatment of primary dysmenorrhea. Current Therapeutic Research1987;42(1):156‐64. ">Costa 1987a</a>). </p> </section> <section id="CD001751-sec-0090"> <h6 class="title">Neurological adverse effects</h6> <p>Seven studies were suitable for meta‐analysis for this outcome, which included adverse effects such as headache, drowsiness, dizziness and dryness of the mouth. They analysed a total of 498 women, 381 in cross‐over studies and 117 in parallel‐group studies, and compared the following NSAIDs versus placebo: naproxen (three studies), indomethacin (two studies) aspirin and fenoprofen (one study each). When we pooled studies NSAIDs were more likely than placebo to cause neurological adverse effects (OR 2.74, 95% CI 1.66 to 4.53, seven studies, I<sup>2</sup> = 0%) (<a href="./references#CD001751-fig-0017" title="">Analysis 1.11</a>). Two individual NSAIDs were associated with a higher incidence of events than placebo: naproxen (OR 2.20, 95% CI 1.11 to 4.35, three studies, I<sup>2</sup> = 0%) and indomethacin (4.96, 95% CI 1.87 to 13.11, two studies, I<sup>2</sup> = 0%). </p> </section> </section> <section id="CD001751-sec-0091"> <h5 class="title">2) NSAIDs versus NSAIDs</h5> <section id="CD001751-sec-0092"> <h6 class="title">All adverse effects</h6> <p>Fifteen studies reported data suitable for meta‐analysis comparing NSAIDs head‐to‐head for this outcome. Only two compared the same two NSAIDs (<a href="./references#CD001751-bbs2-0019" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009a</a>; <a href="./references#CD001751-bbs2-0020" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009b</a>). They analysed data for 1762 women, 959 in cross‐over studies and 803 in parallel studies. They made the following comparisons: aspirin versus fenoprofen, diclofenac versus ibuprofen, etodolac versus piroxicam, ibuprofen versus fenoprofen, ibuprofen versus etoricoxib, mefenamic acid versus tolfenamic acid, and naproxen versus the following: aceclofenac, celecoxib (two studies), diclofenac, etoricoxib, ketoprofen, meclofenamate and piroxicam. When we pooled data for the six studies comparing naproxen versus other NSAIDs we found no evidence of a difference between the groups (<a href="./references#CD001751-fig-0046" title="">Analysis 7.6</a>). Nor did we find any evidence of a difference between the groups in any individual study comparing any NSAIDs head‐to‐head. Two studies not included in meta‐analysis also reported this outcome: one found no evidence of a difference between naproxen and flurbiprofen for the incidence of any adverse effect. The second, comparing diclofenac versus meloxicam, reported no adverse effects in either group (<a href="./references#CD001751-bbs2-0012" title="ChantlerI , MitchellD , FullerA . The effect of three cyclo‐oxygenase inhibitors on intensity of primary dysmenorrhoeic pain. Clinical Journal of Pain2008;24(1):39‐44. ">Chantler 2008</a>). </p> <p>Effect estimates were as follows</p> <p> <ul id="CD001751-list-0024"> <li> <p>Aspirin versus fenoprofen: OR 1.46, 95% CI 0.52 to 4.08, one study (<a href="./references#CD001751-fig-0022" title="">Analysis 2.2</a>). </p> </li> <li> <p>Etodolac versus piroxicam: OR 1.00, 95% CI 0.06 to 16.70, one study (<a href="./references#CD001751-fig-0027" title="">Analysis 3.1</a>). </p> </li> <li> <p>Ibuprofen versus fenoprofen or etoricoxib: OR 1.38, 95% CI 0.68 to 2.80, two studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0030" title="">Analysis 4.3</a>). </p> </li> <li> <p>Mefenamic acid versus tolfenamic acid: OR 1.26, 95% CI 0.54 to 2.96, one study (<a href="./references#CD001751-fig-0034" title="">Analysis 5.3</a>). </p> </li> <li> <p>Diclofenac versus ibuprofen: OR 3.83, 95% CI 0.76 to 19.28, one study (<a href="./references#CD001751-fig-0038" title="">Analysis 6.3</a>). </p> </li> <li> <p>Naproxen versus aceclofenac, diclofenac, etoricoxib, ketoprofen, meclofenamate, piroxicam or celecoxib: OR 1.18, 95% CI 0.92 to 1.53, nine studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0046" title="">Analysis 7.6</a>). </p> </li> </ul> </p> </section> <section id="CD001751-sec-0093"> <h6 class="title">Gastrointestinal adverse effects</h6> <p>Eight studies reported data suitable for meta‐analysis comparing NSAIDs head‐to‐head for gastrointestinal adverse effects such as nausea and indigestion. Two studies compared the same two NSAIDs but the rest compared different NSAIDs. These studies analysed data for 595 women, 176 in cross‐over studies and 419 in parallel‐group studies. They made the following comparisons: aspirin versus fenoprofen, diclofenac versus nimesulide, and naproxen versus the following: ibuprofen, ketoprofen, meclofenamate (each one study) and piroxicam (two studies). When we pooled data for the four studies comparing naproxen with other NSAIDs there was no evidence of a difference between the groups (<a href="./references#CD001751-fig-0047" title="">Analysis 7.7</a>). Nor did any individual study comparing any NSAIDs head‐to‐head find evidence of a difference between the groups for this outcome. </p> <p>Effect estimates were as follows:</p> <p> <ul id="CD001751-list-0025"> <li> <p>Aspirin versus fenoprofen: OR 2.05, 95% CI 0.84 to 4.96, one study (<a href="./references#CD001751-fig-0023" title="">Analysis 2.3</a>). </p> </li> <li> <p>Diclofenac versus nimesulide: OR 2.34, 95% CI 0.93 to 5.87, one study (<a href="./references#CD001751-fig-0039" title="">Analysis 6.4</a>). </p> </li> <li> <p>Naproxen versus ibuprofen, ketoprofen, meclofenamate or piroxicam: OR 1.19, 95% CI 0.53 to 2.69, five studies, I<sup>2</sup> = 0% (<a href="./references#CD001751-fig-0047" title="">Analysis 7.7</a>). </p> </li> </ul> </p> </section> <section id="CD001751-sec-0094"> <h6 class="title">Neurological adverse effects</h6> <p>Five studies reported data suitable for meta‐analysis comparing NSAIDs head‐to‐head for neurological adverse effects such as headache, drowsiness and dizziness. No studies compared the same two NSAIDs. These studies analysed data for 527 women, 108 in cross‐over studies and 419 in parallel‐group studies. They made the following comparisons: aspirin versus fenoprofen, diclofenac versus nimesulide, and naproxen versus ketoprofen, meclofenamate and piroxicam. When we pooled data for the three studies comparing naproxen versus other NSAIDs there was no evidence of a difference between the groups (<a href="./references#CD001751-fig-0048" title="">Analysis 7.8</a>). Nor did any individual study comparing any NSAIDs head‐to‐head find evidence of a difference between the groups for this outcome. </p> <p>Effect estimates were as follows:</p> <p> <ul id="CD001751-list-0026"> <li> <p>Aspirin versus fenoprofen: OR 3.20, 95% CI 0.92 to 11.11, one study (<a href="./references#CD001751-fig-0024" title="">Analysis 2.4</a>). </p> </li> <li> <p>Diclofenac versus nimesulide: OR 0.24, 95% CI 0.03 to 2.02, one study (<a href="./references#CD001751-fig-0040" title="">Analysis 6.5</a>). </p> </li> <li> <p>Naproxen versus ketoprofen, meclofenamate or piroxicam: OR 0.80, 95% CI 0.24 to 2.74, three studies, I<sup>2</sup> = 20% (<a href="./references#CD001751-fig-0048" title="">Analysis 7.8</a>). </p> </li> </ul> </p> </section> </section> <section id="CD001751-sec-0095"> <h5 class="title">3) NSAIDs versus paracetamol</h5> <p>Only three studies reported data suitable for meta‐analysis for this outcome (<a href="./references#CD001751-fig-0053" title="">Analysis 8.2</a> to <a href="./references#CD001751-fig-0055" title="">Analysis 8.4</a>). No evidence of a difference was found between NSAIDs versus paracetamol in the risk of all adverse effects, or gastrointestinal or neurological adverse effects. However, there was only one study for each comparison. </p> <p>Effect estimates were as follows:</p> <p> <ul id="CD001751-list-0027"> <li> <p>All adverse effects: ibuprofen versus paracetamol: OR 0.85, 95% CI 0.31 to 2.34, one study (<a href="./references#CD001751-fig-0053" title="">Analysis 8.2</a>). </p> </li> <li> <p>Gastrointestinal adverse effects: naproxen versus paracetamol: OR 1.00, 95% CI 0.06 to 16.62, one study (<a href="./references#CD001751-fig-0054" title="">Analysis 8.3</a>). </p> </li> <li> <p>Neurological adverse effects: naproxen versus paracetamol: OR 1.54, 95% CI 0.24 to 9.83, one study (<a href="./references#CD001751-fig-0055" title="">Analysis 8.4</a>). </p> </li> </ul> </p> </section> </section> <section id="CD001751-sec-0096"> <h4 class="title">Requirement for additional medication</h4> <section id="CD001751-sec-0097"> <h5 class="title">1. NSAIDs versus placebo</h5> <p>Eighteen studies were suitable for meta‐analysis for this outcome. These studies analysed data for 1283 women, 702 in cross‐over studies and 581 in parallel‐group studies.They compared the following NSAIDs versus placebo: naproxen (11 studies), ibuprofen (three studies), fenoprofen, celecoxib (two studies each), aspirin, diclofenac, piroxicam and mefenamic acid (one study each). Among individual NSAIDs, there was evidence (versus placebo) favouring naproxen (OR 0.37, 95% CI 0.29 to 0.45, 11 studies, I<sup>2</sup> = 48%,), ibuprofen (OR 0.21, 95% CI 0.11 to 0.40, three studies, I<sup>2</sup> = 75%), celecoxib (OR 0.67, 95% CI 0.47 to 0.95, two studies, I<sup>2</sup> = 21%), mefenamic acid (OR 0.48, 95% CI 0.25 to 0.92, two studies, I<sup>2</sup> = 0%) and diclofenac (OR 0.06, 95% CI 0.05 to 0.08, one study, 24 women) (<a href="./references#CD001751-fig-0018" title="">Analysis 1.12</a>). There was no evidence of a difference between other individual NSAIDs and placebo. </p> <p>When we pooled data for this outcome, there was high heterogeneity (I<sup>2</sup> = 98%). This appeared to relate mainly to a small study in which there were no events in the NSAID (diclofenac) arm (<a href="./references#CD001751-bbs2-0037" title="IacovidesS , AvidonI , BentleyA , BakerFC . The 24‐h progression of menstrual pain in women with primary dysmenorrhea when given diclofenac potassium: a randomized,double‐blinded, placebo‐controlled crossover study. Archives of Gynecology and Obstetrics2014;289(5):993‐1002. ">Iacovides 2014</a>). When we omitted this study from analysis, pooling of the data showed a lower rate of requirement for additional medication in the women in the NSAIDs group, and heterogeneity was reduced (OR 0.42, 95% CI 0.36 to 0.50, 17 studies, I<sup>2</sup> = 55%). The placebo groups in two cross‐over studies contributed twice to the pooled analysis but exclusion of these studies did not materially affect the results (<a href="./references#CD001751-bbs2-0019" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009a</a>; <a href="./references#CD001751-bbs2-0020" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009b</a>). </p> </section> <section id="CD001751-sec-0098"> <h5 class="title">2) NSAIDs versus NSAIDs</h5> <p>Seven studies reported data suitable for meta‐analysis for this outcome. Only two compared the same two NSAIDs (<a href="./references#CD001751-bbs2-0019" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009a</a>; <a href="./references#CD001751-bbs2-0020" title="DanielsS , RobbinsJ , WestCR , NemethMA . Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double‐blind, active‐ and placebo‐controlled crossover studies. Clinical Therapeutics2009;31(6):1192‐8. ">Daniels 2009b</a>). They analysed data for 805 women, 458 in cross‐over studies and 347 in parallel‐group studies. They made the following comparisons: aspirin versus fenoprofen, ibuprofen versus piroxicam, ibuprofen versus fenoprofen, ibuprofen verus etoricoxib, naproxen versus celecoxib (two studies) and naproxen versus flurbiprofen. There was no evidence of a difference between any of the NSAIDs compared (<a href="./references#CD001751-fig-0025" title="">Analysis 2.5</a>; <a href="./references#CD001751-fig-0031" title="">Analysis 4.4</a>; <a href="./references#CD001751-fig-0049" title="">Analysis 7.9</a>). </p> </section> <section id="CD001751-sec-0099"> <h5 class="title">3) NSAIDs versus paracetamol</h5> <p>No data were available.</p> </section> </section> <section id="CD001751-sec-0100"> <h4 class="title">Interference with daily activities</h4> <section id="CD001751-sec-0101"> <h5 class="title">1) NSAIDs versus placebo</h5> <p>Five studies were suitable for meta‐analysis for this outcome. These studies analysed data for 306 women, 90 in cross‐over studies and 216 in parallel‐group studies. They compared the following NSAIDs versus placebo: naproxen (three studies), aspirin, fenoprofen and ibuprofen (one study each). Among individual NSAIDs, there was a difference favouring the following NSAIDs over placebo: naproxen (OR 0.45, 95% CI 0.26 to 0.79, three studies, I<sup>2</sup> = 0%), fenoprofen (OR 0.21, 95% CI 0.05 to 0.90) and ibuprofen (OR 0.13, 95% CI 0.05 to 0.32). No evidence of a difference was found between aspirin and placebo. When we pooled all data women in the NSAIDs group were less likely to report interference with daily activities than women in the placebo group (OR 0.32, 95% CI 0.21 to 0.49, five studies, I<sup>2</sup> = 27%) (<a href="./references#CD001751-fig-0019" title="">Analysis 1.13</a>). </p> </section> <section id="CD001751-sec-0102"> <h5 class="title">2) NSAIDs versus NSAIDs</h5> <p>Four studies were suitable for meta‐analysis for this outcome. These studies analysed data for 272 women, 187 in cross‐over studies and 85 in parallel‐group studies. They compared the following NSAIDs: naproxen versus flurbiprofen and ibuprofen, aspirin versus fenoprofen, and mefenamic acid versus tolfenamic acid. Women were less likely to report interference with daily activities when taking naproxen than when taking flurbiprofen (OR 0.33, 95% CI 0.12 to 0.91). No evidence of a difference was found between other individual NSAIDs for this outcome. (<a href="./references#CD001751-fig-0026" title="">Analysis 2.6</a>; <a href="./references#CD001751-fig-0035" title="">Analysis 5.4</a>; <a href="./references#CD001751-fig-0050" title="">Analysis 7.10</a>) </p> </section> <section id="CD001751-sec-0103"> <h5 class="title">3) NSAIDs versus paracetamol</h5> <p>No data were available for this comparison.</p> </section> </section> <section id="CD001751-sec-0104"> <h4 class="title">Absence from work or school</h4> <section id="CD001751-sec-0105"> <h5 class="title">1) NSAIDs versus placebo (five studies)</h5> <p>Four studies, all parallel‐group, were suitable for meta‐analysis for this outcome. These studies analysed data for 235 women. One compared diclofenac versus placebo and the other three compared naproxen versus placebo. There was less absenteeism from work or school among women were taking diclofenac (OR 0.07, 95% CI 0.01 to 0.40) or naproxen (OR 0.20, 95% CI 0.11 to 0.38, three studies, I<sup>2</sup> = 36%) than in the placebo groups. When we pooled the results for the two comparisons, absenteeism was less likely in the NSAIDs group (OR 0.18, 95% CI 0.10 to 0.32, four studies, I<sup>2</sup> = 32%) (<a href="./references#CD001751-fig-0020" title="">Analysis 1.14</a>). One cross‐over trial provided data on this outcome, comparing indomethacin versus placebo. The results favoured indomethacin, but the statistical significance of this finding was not reported (see <a href="#CD001751-tbl-0006">Table 4</a>). </p> <div class="table" id="CD001751-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Absence from work/school: NSAIDs versus placebo (per cycle data)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Piroxicam versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0002" title="AkinluyiEM . Piroxicam in primary dysmenorrhea. Current Therapeutic Research1987;41(6):609‐13. ">Akinluyi 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles in which women needed days off work</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54/80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </div> </section> <section id="CD001751-sec-0106"> <h5 class="title">2) NSAIDs versus NSAIDs (two studies)</h5> <p>Two studies, both cross‐over, were suitable for meta‐analysis for this outcome. These studies analysed data for 114 women. They compared naproxen versus flurbiprofen and versus ibuprofen. No evidence of a difference was found between naproxen and individual NSAIDs for this outcome, nor was there any evidence of a difference between naproxen versus the other NSAIDs when we pooled the data. (<a href="./references#CD001751-fig-0051" title="">Analysis 7.11</a>) </p> </section> <section id="CD001751-sec-0107"> <h5 class="title">3) NSAIDs versus paracetamol</h5> <p>No data were available for this comparison.</p> </section> </section> <section id="CD001751-sec-0108"> <h4 class="title">Heterogeneity</h4> <p>Although the direction of effect in the included studies consistently favoured NSAIDs, there was substantial heterogeneity (P value &lt; 0.1, I<sup>2</sup> &gt; 50%) for some of the analyses, notably when the following NSAIDs were compared with placebo for dichotomous measures of pain relief: piroxicam (I<sup>2</sup> = 69%), mefenamic acid (I<sup>2</sup> = 61%), ibuprofen (I<sup>2</sup> = 60%) and naproxen (I<sup>2</sup> = 52%). The exclusion of two studies that reported no or negligible placebo effect, <a href="./references#CD001751-bbs2-0002" title="AkinluyiEM . Piroxicam in primary dysmenorrhea. Current Therapeutic Research1987;41(6):609‐13. ">Akinluyi 1987</a> and <a href="./references#CD001751-bbs2-0059" title="MorrisonJC , LingFW , FormanEK , BatesGW , BlakePG , VecchioTJ , et al. Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea. Southern Medical Journal1980;73:999‐1002. ">Morrison 1980</a>, resulted in marked decreases in heterogeneity and lower effect measures, as follows: piroxicam (OR 5.81, 95% CI 3.15 to 10.72, two studies, I<sup>2</sup> = 40%), ibuprofen (OR 3.76, 95% CI 2.42 to 5.86, four studies, I<sup>2</sup> = 0%). When we combined all NSAIDs for this outcome the I<sup>2</sup> value was 53%. </p> <p>There was also substantial heterogeneity for the outcome of additional analgesics required, in comparisons of fenoprofen and ibuprofen versus placebo (I<sup>2</sup> = 61%, I<sup>2</sup> = 75% respectively), and in comparisons of naproxen versus celecoxib (I<sup>2</sup> = 69%). In the former case heterogeneity was attributable to a single study in which the requirement for additional analgesics was lower in the placebo group (<a href="./references#CD001751-bbs2-0005" title="ArnoldJD , IberFL , BurtRA , GruberCM . Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea. Journal of Medicine1983;14:337‐50. ">Arnold 1983</a>), but there was no obvious explanation for the heterogeneity in the second instance, and both studies used a similar protocol. </p> <p>Use of a random‐effects model did not materially affect the results.</p> <p>Most other analyses were relatively homogeneous.</p> </section> <section id="CD001751-sec-0109"> <h4 class="title">Funnel plot</h4> <p>Visual scanning of a funnel plot (<a href="#CD001751-fig-0006">Figure 6</a>) for the outcome with most data (NSAIDs versus placebo, dichotomous data) suggested a mild trend towards publication bias, with smaller negative studies less likely to be included in the review. </p> <div class="figure" id="CD001751-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data." data-id="CD001751-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data. </p> </div> </div> </div> </section> <section id="CD001751-sec-0110"> <h4 class="title">Sensitivity analyses</h4> <p>We carried out the pre‐specified sensitivity analyses as follows:</p> <section id="CD001751-sec-0111"> <h5 class="title">1. Exclusion of studies that did not clearly describe adequate procedures for allocation concealment and blinding </h5> <p>There were insufficient studies to conduct this planned sensitivity analysis, as only nine studies in the review clearly described adequate procedures for allocation concealment, of which only six adequately described double‐blinding, and these studies reported the same comparison in only two cases. </p> </section> <section id="CD001751-sec-0112"> <h5 class="title">2. Exclusion of studies with more than 10% of data missing for primary outcomes</h5> <p>We excluded from <a href="./references#CD001751-fig-0007" title="">Analysis 1.1</a> nine studies that did not include at least 90% of randomised women in analysis (<a href="./references#CD001751-bbs2-0009" title="BudoffPW . Mefenamic acid therapy in dysmenorrhea. Advances in Prostaglandin &amp; Thomboxane Research1980;8:1449‐53. BudoffPW . Use of mefenamic acid in the treatment of dysmenorrhea. JAMA1979;241:2713‐6. ">Budoff 1979</a>; <a href="./references#CD001751-bbs2-0017" title="DanielsSE , TalwalkerS , TorriS , SnabesMC , ReckerDP , VerburgKM . Valdecoxib, a cyclo‐oxygenase‐2‐specific inhibitor, is effective in treating primary dysmenorrhea. Obstetrics and Gynecology2002;100:350‐8. ">Daniels 2002</a>; <a href="./references#CD001751-bbs2-0018" title="DanielsS , GittonX , ZhouW , StrickerK , BartonS . Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials. Journal of Women's Health2008;17(3):423‐37. ">Daniels 2008</a>; <a href="./references#CD001751-bbs2-0023" title="DawoodMY , Khan‐DawoodFS . Clinical efficacy and differential inhibition of menstrual fluid prostaglandin F2a in a randomized, double blind crossover treatment with placebo, acetaminophen and ibuprofen in primary dysmenorrhea. American Journal of Obstetrics and Gynecology2007;196(35):e1‐35e5. ">Dawood 2007</a>; <a href="./references#CD001751-bbs2-0032" title="GleesonS , SorbieJ . Efficacy of ketoprofen in treating primary dysmenorrhea. Canadian Medical Association Journal1983;129:842‐4. ">Gleeson 1983</a>; <a href="./references#CD001751-bbs2-0034" title="HansonFW , IzuA , HenzlMR . Naproxen sodium, ibuprofen and a placebo in dysmenorrhea. Its influence in allowing continuation of work/school activities. Obstetrics &amp; Gynecology1978;52:583‐7. ">Hanson 1978</a>; <a href="./references#CD001751-bbs2-0036" title="HenzlMR , ButtramV , SegreEJ , BesslerS . The treatment of dysmenorrhea with naproxen sodium: a report on two independent double‐blind trials. American Journal of Obstetrics &amp; Gynecology1977;127:818‐23. ">Henzl 1977b</a>; <a href="./references#CD001751-bbs2-0039" title="JacobsonJ , Cavalli‐BjokmanK , LundstromV , NilssonB , NorbeckM . Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience. Acta Obstetricia et Gynecologica Scandinavica Supplementum1979;87:73‐9. ">Jacobson 1979</a>; <a href="./references#CD001751-bbs2-0051" title="MehlischDR . Double‐blind crossover comparison of ketoprofen, naproxen and placebo in patients with primary dysmenorrhea. Clinical Therapeutics1990;12:398‐409. ">Mehlisch 1990</a>; <a href="./references#CD001751-bbs2-0061" title="NahidK , FariborzM , AtaolahG , SolokianS . The effect on an Iranian herbal drug on primary dysmenorrhea: a clinical controlled trial. Journal of Midwifery and Women's Health2009;54:401‐4. ">Nahid 2009</a>). This resulted in an odds ratio for pain relief comparing all NSAIDs versus placebo of 4.91 (95% CI 4.10 to 5.87, 26 studies, I<sup>2</sup> = 52%). </p> </section> <section id="CD001751-sec-0113"> <h5 class="title">3. Exclusion of studies in which cross‐over data were analysed as if they derived from parallel‐group studies </h5> <p>We excluded from <a href="./references#CD001751-fig-0007" title="">Analysis 1.1</a> 20 studies in which cross‐over data were analysed in the review as if they derived from parallel‐group studies (<a href="./references#CD001751-bbs2-0002" title="AkinluyiEM . Piroxicam in primary dysmenorrhea. Current Therapeutic Research1987;41(6):609‐13. ">Akinluyi 1987</a>; <a href="./references#CD001751-bbs2-0008" title="BitnerM , KatternhornJ , GaoJ , KellsteinD . Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea. International Journal of Clinical Practice2004;58(4):340‐5. KatternhornJ , HatfieldC , GaoJ , KellsteinD . Lumiracoxib, a novel cyclooxygenase‐2 selective inhibitor, is an effective and well‐tolerated treatment for nausea. International Journal of Obstetrics and Gynaecology2003;83(S3)(Book 2):102. ">Bitner 2004</a>; <a href="./references#CD001751-bbs2-0009" title="BudoffPW . Mefenamic acid therapy in dysmenorrhea. Advances in Prostaglandin &amp; Thomboxane Research1980;8:1449‐53. BudoffPW . Use of mefenamic acid in the treatment of dysmenorrhea. JAMA1979;241:2713‐6. ">Budoff 1979</a>; <a href="./references#CD001751-bbs2-0017" title="DanielsSE , TalwalkerS , TorriS , SnabesMC , ReckerDP , VerburgKM . Valdecoxib, a cyclo‐oxygenase‐2‐specific inhibitor, is effective in treating primary dysmenorrhea. Obstetrics and Gynecology2002;100:350‐8. ">Daniels 2002</a>; <a href="./references#CD001751-bbs2-0018" title="DanielsS , GittonX , ZhouW , StrickerK , BartonS . Efficacy and tolerability of lumiracoxib 200 mg once daily for treatment of primary dysmenorrhea: results from two randomized controlled trials. Journal of Women's Health2008;17(3):423‐37. ">Daniels 2008</a>; <a href="./references#CD001751-bbs2-0021" title="DawoodMY . Efficacy and safety of piroxicam‐B‐cyclodextrin (PBCD, Brexidol). Comparison studies with ibuprofen, naproxen sodium and placebo in the relief of moderate to severe abdominal pain associated with primary dysmenorrhoea. The Brexidol Study Group. Today's Therapeutic Trends1999;17(4):273‐88. ">Dawood 1999a</a>; <a href="./references#CD001751-bbs2-0022" title="DawoodMY . Efficacy and safety of piroxicam‐B‐cyclodextrin (PBCD, Brexidol). Comparison studies with ibuprofen, naproxen sodium and placebo in the relief of moderate to severe abdominal pain associated with primary dysmenorrhoea. The Brexidol Study Group. Today's Therapeutic Trends1999;17(4):273‐88. ">Dawood 1999b</a>; <a href="./references#CD001751-bbs2-0026" title="SouzaAZ , TaclaM , RibeiroRM , HeggR , AguiarLF . Etodolac in primary dysmenorrhea [Etodolac em dismenorreia primaria]. Jornal Brasileiro de Ginecologia1991;101(10):451‐9. ">De Souza 1991</a>; <a href="./references#CD001751-bbs2-0027" title="DiGirolamoG , GimenoMAF , FalettiA , De LosSantosAR , MartiML , ZmijanovichR . Menstrual prostaglandins and dysmenorrhea: modulation by non‐steroidal antiinflammatory drugs [Prostaglandinas menstruales y dismenorrea su modulacion por antiinflamatorios no esteroideos]. Medicina1999;59:259‐64. ">Di Girolamo 1999</a>; <a href="./references#CD001751-bbs2-0032" title="GleesonS , SorbieJ . Efficacy of ketoprofen in treating primary dysmenorrhea. Canadian Medical Association Journal1983;129:842‐4. ">Gleeson 1983</a>; <a href="./references#CD001751-bbs2-0033" title="HamannGO . Severe primary dysmenorrhea treated with naproxen: a prospective, double‐blind crossover investigation. Prostaglandins1980;19:651‐7. ">Hamann 1980</a>; <a href="./references#CD001751-bbs2-0040" title="JacobsonJ , LunstromV , NilssonB . Naproxen in the treatment of OC‐resistant primary dysmenorrhea: a double‐blind cross‐over study. Acta Obstetricia et Gynecologica Scandinavica Supplementum1983;113:87‐9. ">Jacobson 1983</a>; <a href="./references#CD001751-bbs2-0046" title="LegrisM , DuhonR , LarueF , LacosteC . Double‐blind placebo‐controlled study of the efficacy of niflumic acid (750 mg/day in three divided doses) in dysmenorrhea [Essai controle en double aveugle de l'efficacite de l'acide niflumique (750 mg en 3 prises par jour) versus placebo dans les dysmenorrhees]. Revue Francaise de Gynecologie et d'Obstetrique1997;92(4):288‐96. ">Legris 1997</a>; <a href="./references#CD001751-bbs2-0050" title="MarchiniM , RozziL , BakshiR , PistaiR , FedeleL . Comparative study of diclofenac dispersible 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double‐blind, within‐patient, placebo‐controlled study. International Journal of Clinical Pharmacology &amp; Therapeutics1995;33:491‐7. ">Marchini 1995</a>; <a href="./references#CD001751-bbs2-0051" title="MehlischDR . Double‐blind crossover comparison of ketoprofen, naproxen and placebo in patients with primary dysmenorrhea. Clinical Therapeutics1990;12:398‐409. ">Mehlisch 1990</a>; <a href="./references#CD001751-bbs2-0052" title="MehlischDR , FulmerRI . A crossover comparison of bromfenac sodium, and placebo for relief of pain from primary dysmenorrhea. Journal of Women's Health1997;6:83‐92. ">Mehlisch 1997</a>; <a href="./references#CD001751-bbs2-0055" title="MilsomI , MinicM , DawoodMY , AkinMD , SpannJ , NilandNF , et al. Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clinical Therapeutics2002;24(9):1384‐400. MinicM . Personal correspondenceApril 2003. ">Milsom 2002d</a>; <a href="./references#CD001751-bbs2-0059" title="MorrisonJC , LingFW , FormanEK , BatesGW , BlakePG , VecchioTJ , et al. Analgesic efficacy of ibuprofen for treatment of primary dysmenorrhea. Southern Medical Journal1980;73:999‐1002. ">Morrison 1980</a>; <a href="./references#CD001751-bbs2-0071" title="RondelRK , EberhardtR , KochJ , SchurmannW . Treatment of primary essential dysmenorrhoea with nimesulide; a double‐blind cross over study. Current Therapeutic Research1984;35(1):123‐9. ">Rondel 1984</a>; <a href="./references#CD001751-bbs2-0079" title="WilhelmssonL , JonssonK , HallingL , HermannM , JaderlingJ , LindellC , et al. Piroxicam in the treatment of primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica1985;64:317‐21. ">Wilhelmsson 1985b</a>). This resulted in an odds ratio for pain relief (all NSAIDs versus placebo) of 5.73 (95% CI 4.45 to 7.38, 19 studies, I<sup>2</sup> = 18%). For the outcome of all adverse events (all NSAIDs versus placebo), exclusion of studies in which cross‐over data were analysed as if they derived from parallel‐group studies resulted in an OR of 1.41 (0.97 to 2.05, six studies). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001751-sec-0114" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001751-sec-0114">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001751-sec-0166">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001751-sec-0114"></div> <section id="CD001751-sec-0115"> <h3 class="title" id="CD001751-sec-0115">Summary of main results</h3> <section id="CD001751-sec-0116"> <h4 class="title">Efficacy of NSAIDs</h4> <p>The trials included in this review suggested that nonsteroidal anti‐inflammatory drugs (NSAIDs) are very effective in providing pain relief from dysmenorrhoea. Almost all measures of effectiveness confirmed the overall superiority over placebo of all NSAIDs tested (with the exception of aspirin, about which the volume of evidence was very small). The evidence suggests that if 18% of women taking placebo achieve moderate or excellent pain relief, between 45% and 53% taking NSAIDs will do so. </p> <p>When NSAIDs were compared with each other, most studies found no evidence of a difference between them. Despite the large number of included trials, only two reported data suitable for meta‐analysis comparing the same two NSAIDs, and sample sizes were generally small. Thus the review was unable to determine which NSAIDs are most effective for dysmenorrhoea nor to determine whether individual NSAIDs have similar efficacy. </p> <p>Three studies compared NSAIDs with paracetamol. Pooling of these studies found NSAIDs to be more effective for pain relief than paracetamol. </p> </section> <section id="CD001751-sec-0117"> <h4 class="title">Tolerability and safety of NSAIDs</h4> <p>As might be anticipated, NSAIDs appeared overall more likely than placebo to cause adverse effects. Mild neurological adverse effects (such as headache, drowsiness, dizziness and dryness) and gastrointestinal adverse effects (such as nausea and indigestion) were both more common in the NSAIDs group. It is important for women taking NSAIDs for dysmenorrhoea to be aware of the need to take the medications with food, even though they are administered only for short‐term use. </p> <p>Among individual NSAIDs, indomethacin was more likely to cause neurological side effects than placebo, dexketoprofen was more likely to cause gastrointestinal side effects and naproxen was more likely to cause both. The findings for naproxen probably relate to the large number of studies on naproxen, compared to other NSAIDs. When NSAIDs were compared with each other, there was no evidence of any difference between them with respect to adverse effects. </p> <p>The large number of NSAIDs involved in these comparisons reflects the abundance of NSAIDs available. Others have been withdrawn from the world market after doubts emerged about their safety. All the NSAIDs included in comparisons in this review are currently available, to the best of our knowledge, in various parts of the world, but at least one (nimesulide) has been the subject of a risk/benefit review after safety concerns were raised (<a href="./references#CD001751-bbs2-0218" title="The European Agency for the Evaluation of Medicinal Products. Press release EMEA website 26 April 2002. http://www.emea.eu.int/pdfs/human/press/pr/174702en.pdf (accessed 7 April 2003; link no longer operating July 2015). ">EMEA 2002</a>). </p> </section> <section id="CD001751-sec-0118"> <h4 class="title">Traditional NSAIDs versus COX‐2‐specific inhibitors</h4> <p>Although we retrieved a number of studies of COX‐2 inhibitors in the search for the update of this review, we excluded several as they involved NSAIDs that have been withdrawn by the manufacturers due to safety concerns. We ultimately included only two COX‐2‐specific inhibitors in the review: celecoxib and etoricoxib. Celecoxib was less effective for pain relief than naproxen and there was no evidence of any difference between etoricoxib and naproxen. There was no evidence of any difference in tolerability between non‐selective and COX‐2‐specific inhibitors, though data were very scarce. </p> </section> </section> <section id="CD001751-sec-0119"> <h3 class="title" id="CD001751-sec-0119">Overall completeness and applicability of evidence</h3> <p>As noted above, due to the lack of studies comparing NSAIDs head‐to‐head we were unable to determine which specific NSAID is most effective or whether individual NSAIDs have similar efficacy. </p> <p>It would be useful to know whether it is possible to maintain the benefits of NSAIDs but reduce adverse effects by combining lower doses of NSAIDs with paracetamol, codeine, transcutaneous electrical nerve stimulation (TENS) or acupuncture. It would also be useful to know whether dysmenorrhoea in intrauterine contraceptive device (IUCD) users can be treated in a similar way to primary dysmenorrhoea. However, these questions lie outside the scope of the present review. </p> </section> <section id="CD001751-sec-0120"> <h3 class="title" id="CD001751-sec-0120">Quality of the evidence</h3> <p>With respect to risk of bias, most studies considered for this review were of poor calibre. We excluded nearly 50 for unclear design, lack of double‐blinding or very large numbers of withdrawals, while among the included studies very few clearly described their methods of randomisation and allocation concealment. Recently published studies appeared to be no more likely than older studies to adequately describe their methods (e.g. allocation concealment). Nearly 60% of the studies were co‐authored or financially supported by pharmaceutical company associates and it was unclear how most of the others were funded. Moreover the funnel plot suggested a mild trend towards publication bias, with smaller negative studies less likely to be included in the review. </p> <p>Reporting of pain relief using a dichotomous measure or visual analogue scale (VAS) provides clinically meaningful results and facilitates meta‐analysis. The included studies used a wide variety of continuous pain scales as their primary or sole measure of effectiveness. We tried combining different continuous measures of final pain score and calculating the standardised mean difference, but findings were highly heterogeneous (I<sup>2</sup> = 77%), suggesting that the different scales may not have been measuring the same concept. We recommend the use of standard, validated scales for pain, such as VAS. </p> <p>The measurement and reporting of adverse effects was generally poor, even taking into account the challenge of distinguishing between dysmenorrhoeic symptoms and medication effects. Only 30% of the studies described the use of prospective self report forms or diaries. The rest assessed adverse effects retrospectively at follow‐up appointments, were vague about their methods or failed to systematically report adverse effects. It is important that studies report numerical results for all outcomes and not just for significant or selected findings. The available evidence suggests that if 10% of women taking placebo experience side effects, between 11% and 14% of women taking NSAIDs will do so. </p> <p>As there were insufficient studies to conduct a sensitivity analysis to explore the effect of adequate allocation concealment and double‐blinding, the extent to which bias affected estimates of effect is unclear. Moreover the funnel plot suggests the possibility of publication bias, which may have inflated the positive findings for NSAIDs in this review. </p> </section> <section id="CD001751-sec-0121"> <h3 class="title" id="CD001751-sec-0121">Potential biases in the review process</h3> <p>The cross‐over design requires that each study participant receives two or more treatments in a random order, each participant thus acting as her own control. Cross‐over trials are suitable for evaluating interventions with a temporary effect in the treatment of stable, chronic conditions (<a href="./references#CD001751-bbs2-0223" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). This design was used by most of the included trials, and seems appropriate for exploring the use of NSAIDs for dysmenorrhoea, since dysmenorrhoea is a chronic, recurring problem and the half life of NSAIDs varies widely but is under 60 hours (<a href="./references#CD001751-bbs2-0210" title="BrooksPM , DayRO . Non‐steroidal anti‐inflammatory drugs ‐ differences and similarities. New England Journal of Medicine1999;324:1716‐25. ">Brooks 1999</a>). In order for cross‐over trials to be given adequate weight in meta‐analysis, study authors need to report an explicit statement that they used paired statistical analysis, plus a summary effect measure and an estimate of variability for each outcome. As very few cross‐over trials in the review provided this information, most were analysed as if they used a parallel design. As a result their findings may have been under‐weighted in analysis, resulting in wider confidence intervals than would otherwise be the case. Sensitivity analysis excluding cross‐over studies that did not meet these criteria resulted in a much higher estimate of analgesic effectiveness (odds ratio (OR) 7.04 versus OR 4.44). This was probably partly due to confounding by study age, since many of the studies included in the analysis were older parallel‐group studies, which overall tended to report higher effect estimates than the more recent studies. </p> </section> <section id="CD001751-sec-0122"> <h3 class="title" id="CD001751-sec-0122">Agreements and disagreements with other studies or reviews</h3> <p>Our findings are in accordance with a systematic review of NSAIDs and hormonal contraceptives for dysmenorrhoea published in 2010 (<a href="./references#CD001751-bbs2-0239" title="ZahradnikHP , Hanjalic‐BeckA , GrothK . Nonsteroidal anti‐inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception2010;81:185‐96. ">Zahradnik 2010</a>), which was based on a search of a single database (PubMed). It included 10 randomised controlled trials (RCTs) of NSAIDs and concluded that NSAIDs are suitable as a first‐line therapy for treating dysmenorrhoea in women without wish for contraception. This review went on to suggest that combined oral contraceptives are a more suitable option for women requiring contraception. As noted above, the use of oral contraceptives for dysmenorrhoea is the topic of another Cochrane review (<a href="./references#CD001751-bbs2-0238" title="WongCL , FarquharC , RobertsH , ProctorM . Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD002120.pub3] ">Wong 2009</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001751-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001751-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Data extraction form" data-id="CD001751-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Data extraction form</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD001751-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study." data-id="CD001751-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data." data-id="CD001751-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data." data-id="CD001751-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 NSAIDs vs placebo, outcome: 1.1 Pain relief dichotomous data. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 1 Pain relief dichotomous data." data-id="CD001751-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 1 Pain relief dichotomous data.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 2 Pain relief continuous data: % improvement in VAS pain score (scale 1 to 100)." data-id="CD001751-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 2 Pain relief continuous data: % improvement in VAS pain score (scale 1 to 100). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 3 Pain relief continuous data: total pain relief score difference." data-id="CD001751-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 3 Pain relief continuous data: total pain relief score difference. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 4 Pain relief continuous data: final pain relief score difference (repeated 0 to 3 scale)." data-id="CD001751-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 4 Pain relief continuous data: final pain relief score difference (repeated 0 to 3 scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 5 Pain relief continuous data: final pain relief score difference (one‐off scales)." data-id="CD001751-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 5 Pain relief continuous data: final pain relief score difference (one‐off scales). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 6 Pain intensity continuous data: mean difference final scores (5‐point scale)." data-id="CD001751-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 6 Pain intensity continuous data: mean difference final scores (5‐point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 7 Pain intensity continuous data: mean difference final scores (4‐point scale)." data-id="CD001751-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 7 Pain intensity continuous data: mean difference final scores (4‐point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0014"> <p> <div class="table" id="CD001751-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome measure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Design (number analysed)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Result</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Naproxen vs placebo</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mehlisch 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naproxen 550 mg vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Global assessment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cross‐over (n = 57)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naproxen superior P value = 0.001</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 8 Pain relief descriptive data.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0014">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001751-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 9 All adverse effects." data-id="CD001751-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 9 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 10 Gastrointestinal adverse effects." data-id="CD001751-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 10 Gastrointestinal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 11 Neurological adverse effects." data-id="CD001751-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 11 Neurological adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 12 Additional analgesics required." data-id="CD001751-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 12 Additional analgesics required.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 13 Interference with daily activities." data-id="CD001751-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 13 Interference with daily activities.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 NSAIDs vs placebo, Outcome 14 Absence from school/work." data-id="CD001751-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 NSAIDs vs placebo, Outcome 14 Absence from school/work.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Aspirin vs NSAIDs, Outcome 1 Pain intensity continuous data final pain relief score difference (0‐ to 3‐point scale)." data-id="CD001751-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Aspirin vs NSAIDs, Outcome 1 Pain intensity continuous data final pain relief score difference (0‐ to 3‐point scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Aspirin vs NSAIDs, Outcome 2 All adverse effects." data-id="CD001751-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Aspirin vs NSAIDs, Outcome 2 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Aspirin vs NSAIDs, Outcome 3 Gastrointestinal adverse effects." data-id="CD001751-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Aspirin vs NSAIDs, Outcome 3 Gastrointestinal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Aspirin vs NSAIDs, Outcome 4 Neurological adverse effects." data-id="CD001751-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Aspirin vs NSAIDs, Outcome 4 Neurological adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Aspirin vs NSAIDs, Outcome 5 Additional analgesics required." data-id="CD001751-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Aspirin vs NSAIDs, Outcome 5 Additional analgesics required.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Aspirin vs NSAIDs, Outcome 6 Interference with daily activities." data-id="CD001751-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Aspirin vs NSAIDs, Outcome 6 Interference with daily activities.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Etodolac vs NSAIDs, Outcome 1 All adverse events." data-id="CD001751-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Etodolac vs NSAIDs, Outcome 1 All adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ibuprofen vs NSAIDs, Outcome 1 Pain relief: dichotomous outcome." data-id="CD001751-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Ibuprofen vs NSAIDs, Outcome 1 Pain relief: dichotomous outcome.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ibuprofen vs NSAIDs, Outcome 2 Pain relief continuous data: final pain relief score difference (time‐weighted TOPAR‐6 scale)." data-id="CD001751-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Ibuprofen vs NSAIDs, Outcome 2 Pain relief continuous data: final pain relief score difference (time‐weighted TOPAR‐6 scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ibuprofen vs NSAIDs, Outcome 3 All adverse effects." data-id="CD001751-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Ibuprofen vs NSAIDs, Outcome 3 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ibuprofen vs NSAIDs, Outcome 4 Additional analgesics required." data-id="CD001751-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Ibuprofen vs NSAIDs, Outcome 4 Additional analgesics required.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mefenamic acid vs NSAIDs, Outcome 1 Pain relief: dichotomous data." data-id="CD001751-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Mefenamic acid vs NSAIDs, Outcome 1 Pain relief: dichotomous data.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mefenamic acid vs NSAIDs, Outcome 2 Pain relief (VAS)." data-id="CD001751-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Mefenamic acid vs NSAIDs, Outcome 2 Pain relief (VAS).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mefenamic acid vs NSAIDs, Outcome 3 All adverse effects." data-id="CD001751-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Mefenamic acid vs NSAIDs, Outcome 3 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Mefenamic acid vs NSAIDs, Outcome 4 Interference with daily activities." data-id="CD001751-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Mefenamic acid vs NSAIDs, Outcome 4 Interference with daily activities.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Diclofenac vs NSAIDs, Outcome 1 Pain relief dichotomous data." data-id="CD001751-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Diclofenac vs NSAIDs, Outcome 1 Pain relief dichotomous data.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Diclofenac vs NSAIDs, Outcome 2 Pain relief: mean difference VAS reduction." data-id="CD001751-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Diclofenac vs NSAIDs, Outcome 2 Pain relief: mean difference VAS reduction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Diclofenac vs NSAIDs, Outcome 3 All adverse effects." data-id="CD001751-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Diclofenac vs NSAIDs, Outcome 3 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Diclofenac vs NSAIDs, Outcome 4 Gastrointestinal adverse effects." data-id="CD001751-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Diclofenac vs NSAIDs, Outcome 4 Gastrointestinal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Diclofenac vs NSAIDs, Outcome 5 Neurological adverse effects." data-id="CD001751-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Diclofenac vs NSAIDs, Outcome 5 Neurological adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 1 Pain relief: dichotomous outcome." data-id="CD001751-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 1 Pain relief: dichotomous outcome.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 2 Pain intensity (SPID)." data-id="CD001751-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 2 Pain intensity (SPID).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 3 Pain relief: continuous data: total pain relief score difference." data-id="CD001751-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 3 Pain relief: continuous data: total pain relief score difference. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 4 Pain relief: continuous data: mean difference final scores 1 to 5 scale." data-id="CD001751-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 4 Pain relief: continuous data: mean difference final scores 1 to 5 scale. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 5 Pain relief: continuous data: mean difference change scores." data-id="CD001751-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 5 Pain relief: continuous data: mean difference change scores. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 6 All adverse effects." data-id="CD001751-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 6 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 7 Gastrointestinal adverse effects." data-id="CD001751-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 7 Gastrointestinal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 8 Neurological adverse effects." data-id="CD001751-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 8 Neurological adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 9 Additional analgesics required." data-id="CD001751-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 9 Additional analgesics required.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 10 Interference with daily activities." data-id="CD001751-fig-0050" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 10 Interference with daily activities.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-007-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-007-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Naproxen vs NSAIDs, Outcome 11 Absence from work/school." data-id="CD001751-fig-0051" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 Naproxen vs NSAIDs, Outcome 11 Absence from work/school.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-007-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 NSAIDs vs paracetamol, Outcome 1 Pain relief dichotomous data." data-id="CD001751-fig-0052" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 NSAIDs vs paracetamol, Outcome 1 Pain relief dichotomous data.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 NSAIDs vs paracetamol, Outcome 2 All adverse effects." data-id="CD001751-fig-0053" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 NSAIDs vs paracetamol, Outcome 2 All adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 NSAIDs vs paracetamol, Outcome 3 Gastrointestinal adverse effects." data-id="CD001751-fig-0054" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 NSAIDs vs paracetamol, Outcome 3 Gastrointestinal adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001751-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/urn:x-wiley:14651858:media:CD001751:CD001751-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_t/tCD001751-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 NSAIDs vs paracetamol, Outcome 4 Neurological adverse effects." data-id="CD001751-fig-0055" src="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 NSAIDs vs paracetamol, Outcome 4 Neurological adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/media/CDSR/CD001751/image_n/nCD001751-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001751-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NSAIDs compared to placebo for dysmenorrhoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NSAIDs compared to placebo for dysmenorrhoea</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women with primary dysmenorrhoea </p> <p><b>Setting: Outpatient</b> <br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of studies</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk<sup>4</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> NSAIDs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain relief dichotomous data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>490 per 1000<br/> (452 to 528) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 4.37<br/> (3.76 to 5.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All adverse effects</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>125 per 1000<br/> (110 to 144) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.29<br/> (1.11 to 1.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in a footnote. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NSAID:</b> nonsteroidal anti‐inflammatory drug; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Very poor reporting of study methods by over 75% of studies; high risk of attrition bias in several studies; over 60% of studies commercially sponsored.<br/> <sup>2</sup>Substantial heterogeneity (I² = 53%) but direction of effect consistent.<br/> <sup>3</sup>Some suggestion of publication bias, favouring small studies with positive findings for NSAIDs.<br/> <sup>4</sup>The control group risks are calculated from median values in 31 studies of pain relief and 19 of adverse effects in a previous version of this review. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">NSAIDs compared to placebo for dysmenorrhoea</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001751-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAIDs compared to paracetamol for dysmenorrhoea</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>NSAIDs compared to paracetamol for dysmenorrhoea</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women with primary dysmenorrhoea </p> <p><b>Setting: Outpatient</b> <br/> <b>Intervention:</b> NSAIDs<br/> <b>Comparison:</b> paracetamol </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of studies</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk<sup>3</sup> </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Paracetamol</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> NSAIDs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain relief dichotomous data</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>630 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>763 per 1000<br/> (641 to 854) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 1.89<br/> (1.05 to 3.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 studies</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All adverse effects ‐ ibuprofen versus paracetamol</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>130 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>113 per 1000<br/> (44 to 259) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.85<br/> (0.31 to 2.34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is provided in a footnote. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>NSAID:</b> nonsteroidal anti‐inflammatory drug; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Poor reporting of study methods in two of the studies; high risk of attrition bias in one study; two of the studies commercially funded.<br/> <sup>2</sup>One small study, findings compatible with benefit/harm from either intervention, or with no difference between the interventions.<br/> <sup>3</sup>The control group risk is calculated from the median value in the included studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">NSAIDs compared to paracetamol for dysmenorrhoea</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001751-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Pain relief: NSAIDs versus placebo (per cycle data)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where treatment gave moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13/89</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Indomethacin versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles when women reported moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nimesulide versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0069" title="PulkkinenMO . Alterations in intrauterine pressure, menstrual fluid prostaglandin F levels, and pain in dysmenorrheic women treated with nimesulide. Journal of Clinical Pharmacology1987;27:65‐9. ">Pulkkinen 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where women rated therapy good/very effective</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22/28</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9/27</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.01</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diclofenac versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0070" title="RiihiluomaP , WuolijokiE , PulkkinenMO . Treatment of primary dysmenorrhea with diclofenac sodium. European Journal of Obstetrics, Gynecology &amp; Reproductive Biology1981;12:189‐94. ">Riihiluoma 1981</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles when pain much improved</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14/58</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3/57</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.05</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Pain relief: NSAIDs versus placebo (per cycle data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001751-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pain relief: NSAIDs versus placebo: median data</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo group</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>P value</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Finding</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mefenamic acid versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0061" title="NahidK , FariborzM , AtaolahG , SolokianS . The effect on an Iranian herbal drug on primary dysmenorrhea: a clinical controlled trial. Journal of Midwifery and Women's Health2009;54:401‐4. ">Nahid 2009</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (106 analysed)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain score: median (range)</p> <p>on 1 to 10 VAS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n = 55</p> <p>At 2 months: 3.6 (2 to 6)</p> <p>At 3 months: 2.4 (1 to 5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>n = 51</p> <p>At 2 months: 5 (2 to 6)</p> <p>At 3 months: 6 (4 to 7)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours NSAID</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Pain relief: NSAIDs versus placebo: median data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001751-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pain relief: NSAIDs versus NSAIDs (per cycle data)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 1</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 2</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 1</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID 2</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aspirin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Indomethacin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0041" title="KajanojaP . Indomethacin in the treatment of primary dysmenorrhea. Archiv fur Gynakologie1978;225:1‐5. ">Kajanoja 1978</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where treatment gave moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13/89</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42/90</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P value &lt; 0.001</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diflunisal</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0042" title="KajanojaP . Difusinal compared with naproxen in the treatment of dysmenorrhea. Prostaglandins, Leukotrienes and Medicine1984;15:153‐8. ">Kajanoja 1984</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22 (19 analysed)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles where treatment achieved moderate/good relief</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34/38</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28/38 cycles</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not statistically significant</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pain relief: NSAIDs versus NSAIDs (per cycle data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001751-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Absence from work/school: NSAIDs versus placebo (per cycle data)</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study ID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>No of women</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Outcome measure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAID</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Significance</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Piroxicam versus placebo</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001751-bbs2-0002" title="AkinluyiEM . Piroxicam in primary dysmenorrhea. Current Therapeutic Research1987;41(6):609‐13. ">Akinluyi 1987</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>60</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No of cycles in which women needed days off work</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6/80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54/80</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>NSAID = nonsteroidal anti‐inflammatory drug</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Absence from work/school: NSAIDs versus placebo (per cycle data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/full#CD001751-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs vs placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain relief dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.37 [3.76, 5.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Diclofenac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.68 [3.03, 10.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Etodolac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.75 [1.14, 6.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Ibuprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.22 [3.62, 7.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Indomethacin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>23.59 [6.01, 92.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Ketoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.02 [2.98, 12.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.67 [2.94, 4.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 Piroxicam vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.21 [4.85, 13.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.98 [1.66, 5.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9 Niflumic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [1.01, 4.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10 Nimesulide vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.31 [2.39, 16.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11 Lysine clonixinate vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.86 [1.49, 41.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain relief continuous data: % improvement in VAS pain score (scale 1 to 100) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Diclofenac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>65.96 [55.70, 76.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Meloxicam vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>34.0 [15.88, 52.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain relief continuous data: total pain relief score difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.24 [4.69, 7.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Celecoxib (COX‐2‐specific): vs placebo TOPAR difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.46 [2.29, 8.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Etoricoxib (COX‐2‐specific): vs placebo TOPAR difference (time‐weighted scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.4 [3.17, 11.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Naproxen vs placebo TOPAR difference (time‐weighted scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.28 [4.34, 8.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain relief continuous data: final pain relief score difference (repeated 0 to 3 scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.83 [3.61, 6.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Flufenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.91 [3.50, 6.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Indomethacin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.6 [2.12, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain relief continuous data: final pain relief score difference (one‐off scales) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Indomethacin vs placebo (0 to 18 scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.2 [7.24, 15.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Naproxen vs placebo (0 to 40 scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.30 [5.64, 24.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pain intensity continuous data: mean difference final scores (5‐point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.84, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Aspirin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.72, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Fenoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.65 [‐1.37, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pain intensity continuous data: mean difference final scores (4‐point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.7 [‐3.37, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.7 [‐3.37, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pain relief descriptive data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.11, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Aceclofenac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.53, 4.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Aspirin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [0.49, 7.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Celecoxib (COX‐2‐specific): vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.72, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4 Dexketoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.47, 5.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5 Diclofenac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.91, 4.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.6 Etodolac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.41, 7.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.7 Etoricoxib (COX‐2‐specific): vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.81, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.8 Fenoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.58, 2.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.9 Ibuprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.71, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.10 Ketoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.59, 2.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.11 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.00, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.12 Niflumic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.53 [0.67, 9.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.13 Nimesulide vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.39 [0.15, 368.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.14 Piroxicam vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.72, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Gastrointestinal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.58 [1.12, 2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Aspirin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.55, 3.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Dexketoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.08 [1.96, 42.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Fenoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.22, 6.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 Indomethacin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.54, 2.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.5 Ketoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.06 [0.50, 130.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.84, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [1.02, 5.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.8 Piroxicam vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.13, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neurological adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.74 [1.66, 4.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Aspirin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.66 [0.75, 17.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Fenoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.22, 11.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 Indomethacin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.96 [1.87, 13.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [1.11, 4.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.5 Piroxicam vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Additional analgesics required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.18, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Aspirin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.18, 2.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Celecoxib (COX‐2‐specific): vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.47, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Diclofenac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.05, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 Fenoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.27, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 Ibuprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.11, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6 Mefenamic acid vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.13, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.7 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.29, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.8 Piroxicam vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.06, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Interference with daily activities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.21, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Aspirin vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.11, 1.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Fenoprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.05, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Ibuprofen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.05, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.26, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Absence from school/work <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.10, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Diclofenac vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [0.01, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Naproxen vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.11, 0.38]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">NSAIDs vs placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Aspirin vs NSAIDs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain intensity continuous data final pain relief score difference (0‐ to 3‐point scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.10, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Aspirin vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.10, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.52, 4.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Aspirin vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.52, 4.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Gastrointestinal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.84, 4.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Aspirin vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.77 [0.53, 5.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Aspirin vs indomethacin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.42 [0.66, 8.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neurological adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.92, 11.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Aspirin vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.20 [0.92, 11.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Additional analgesics required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.73, 5.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Aspirin vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.73, 5.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Interference with daily activities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.57 [0.81, 8.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Aspirin vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.57 [0.81, 8.17]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Aspirin vs NSAIDs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Etodolac vs NSAIDs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Etodolac vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.70]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Etodolac vs NSAIDs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ibuprofen vs NSAIDs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain relief: dichotomous outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.55, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Ibuprofen vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.53, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Ibuprofen vs lysine clonixinate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.26, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain relief continuous data: final pain relief score difference (time‐weighted TOPAR‐6 scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Ibuprofen vs etoricoxib TOPAR 6 difference (time‐weighted scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.89 [‐1.74, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.68, 2.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Ibuprofen vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.51 [0.72, 3.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Ibuprofen vs etoricoxib</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.04, 5.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Additional analgesics required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.44, 2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Ibuprofen vs fenoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.21, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Ibuprofen vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.21, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Ibuprofen vs etoricoxib</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.10 [0.45, 37.25]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ibuprofen vs NSAIDs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Mefenamic acid vs NSAIDs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain relief: dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.32, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Mefenamic acid vs meloxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.32, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain relief (VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.69, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Mefenamic acid vs tolfenamic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.69, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.54, 2.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Mefenamic acid vs tolfenamic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.54, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Interference with daily activities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [‐0.34, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Mefenamic acid vs tolfenamic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [‐0.34, 1.42]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Mefenamic acid vs NSAIDs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Diclofenac vs NSAIDs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain relief dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.57, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Diclofenac vs ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.61, 2.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Diclofenac vs nimesulide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.38, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain relief: mean difference VAS reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>34.0 [15.88, 52.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Diclofenac vs meloxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>34.0 [15.88, 52.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.83 [0.76, 19.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Diclofenac vs ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.83 [0.76, 19.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Gastrointestinal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.34 [0.93, 5.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Diclofenac vs nimesulide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.34 [0.93, 5.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Neurological adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Diclofenac vs nimesulide</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 2.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Diclofenac vs NSAIDs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Naproxen vs NSAIDs</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain relief: dichotomous outcome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.36, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Naproxen vs ketoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.16, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Naproxen vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.37, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain intensity (SPID) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.28, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Naproxen vs flurbiprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.28, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain relief: continuous data: total pain relief score difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.44 [0.83, 4.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Naproxen vs etoricoxib (COX‐2‐specific): TOPAR8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐1.47, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Naproxen vs celecoxib (COX‐2‐specific): TOPAR8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.84 [0.92, 4.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain relief: continuous data: mean difference final scores 1 to 5 scale <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.39, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Naproxen vs ibuprofen: 1 to 5 scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.27 [‐0.53, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Naproxen vs diclofenac: 1 to 5 scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.1 [‐0.33, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain relief: continuous data: mean difference change scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.1 [0.56, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Naproxen vs ketoprofen: VAS 0 to 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.1 [0.56, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.92, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Naproxen vs aceclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.55, 3.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Naproxen vs diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.45, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Naproxen vs etoricoxib</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.49, 3.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Naproxen vs ketoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.33, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Naproxen vs meclofenamate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.05 [0.38, 24.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 Naproxen vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.66, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7 Naproxen vs celecoxib</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.84, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Gastrointestinal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.53, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Naproxen vs ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.20, 4.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Naproxen vs ketoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 5.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Naproxen vs meclofenamate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.05 [0.20, 21.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Naproxen vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.44, 4.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neurological adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.24, 2.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Naproxen vs ketoprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.17, 23.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Naproxen vs meclofenamate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.39 [0.15, 368.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Naproxen vs piroxicam</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.09, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Additional analgesics required <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.52, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Naproxen vs flurbiprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.18, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Naproxen vs celecoxib</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.52, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Interference with daily activities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.33, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 Naproxen vs flurbiprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.12, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 Naproxen vs ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.43, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Absence from work/school <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.19, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Naproxen vs flurbiprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.02, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Naproxen vs ibuprofen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.23, 2.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Naproxen vs NSAIDs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001751-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">NSAIDs vs paracetamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Pain relief dichotomous data <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [1.05, 3.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Ibuprofen vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [0.83, 3.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Naproxen vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.25 [0.81, 6.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.31, 2.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Ibuprofen vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.31, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Gastrointestinal adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Naproxen vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 16.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neurological adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.24, 9.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Naproxen vs paracetamol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.24, 9.83]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">NSAIDs vs paracetamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001751.pub3/references#CD001751-tbl-0014">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001751.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001751-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001751-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001751-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD001751-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD001751-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD001751-note-0003">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD001751-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001751\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001751\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001751\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001751\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001751\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001751.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001751.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001751.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001751.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001751.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719329088"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001751.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719329091"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001751.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de6142dff9368',t:'MTc0MDcxOTMyOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 